WO2012045680A2

WO2012045680A2 - Insecticidal and fungicidal active substance combinations

Info

Publication number: WO2012045680A2
Application number: PCT/EP2011/067137
Authority: WO
Inventors: Peter Jeschke; Heike Hungenberg; Robert Velten; Leonardo PITTÁ
Original assignee: Bayer Cropscience Ag
Priority date: 2010-10-04
Filing date: 2011-09-30
Publication date: 2012-04-12
Also published as: WO2012045680A3

Abstract

The present invention relates to active substance combinations which contain firstly a halogen-substituted compound of the formula (I) and secondly one or more further pesticidal active substances, and which are suitable for controlling animal and microbial pests.

Description

Insecticidal and fungicidal combinations of active substances

This application relates to mixtures of halogen-substituted compounds of formula (I) explained below with at least one further active ingredient, which may preferably be an insecticide or an acaricide or a nematicide or an antimicrobial compound. These mixtures (drug combinations) are suitable for controlling animal or microbial pests and as a plant tonic.

The halogen-substituted compounds are known from WO 2008/009360, where their use for controlling animal pests is described. However, the acaricidal and / or insecticidal and / or nematicidal activity and / or range of action and / or the plant tolerance, in particular to crops, of these compounds is not always sufficient.

It has now been found that drug combinations (drug mixtures) comprising one or more compounds of the formula (I) and one or more compounds from the groups (1-1) to (1-29) described below and / or one or more compounds the groups (Fl) to (F-14) described below are synergistically effective and are suitable for controlling animal and microbial pests and as a plant tonic.

The active compound combinations according to the invention contain at least one and preferably exactly one compound of the formula (I),

in which

A is in each case optionally substituted aryl, heterocyclyl or hetaryl which is optionally substituted by fluorine, chlorine, bromine, iodine, cyano, nitro, alkyl (which is optionally substituted by fluorine and / or chlorine), alkylthio (which is optionally substituted by fluorine and / or Chlorine is substituted), or alkylsulfonyl (which is optionally substituted by fluorine and / or chlorine) are substituted,

R ^{1 is} in each case halogen-substituted C ₂ -C ₄ -alkyl, C ₂ -C ₅ -alkenyl or C ₃ -C ₅ -cycloalkyl,

R ^{2 is} in each case optionally halogen-substituted alkyl or cycloalkyl, represents optionally substituted methylene or in each case optionally substituted alkylene or alkylidene having in each case 2 to 6 carbon atoms, or denotes a bond between A and NR ¹ .

Preferred substituents or ranges of the radicals listed in the formulas mentioned above and below are explained below. is preferably tetrahydrofuryl, or is pyrid-3-yl which is optionally substituted in 6-position by halogen, C ₄ alkyl or _Ci-C4 haloalkyl, or for pyrimidin-5-yl which is optionally substituted in the 2 position by halogen or C 1 -C ₄ -alkyl or for 1H-pyrazol-4-yl which is optionally substituted in the 1-position by C 1 -C ₄ -alkyl and in the 3-position by halogen or for 1H-pyrazol-5-yl which is optionally substituted in the 3-position by halogen or Ci-C-alkyl or isoxazol-5-yl, which is optionally substituted in the 3-position by halogen or Ci-C-alkyl or for l, 2,4-oxadiazole -5-yl, which is optionally substituted in the 3-position by halogen or Ci-C alkyl or for l-methyl-l, 2,4-triazol-3-yl, 1,2,5-thiadiazol-3-yl or for l, 3-thiazolyl-5-yl, which is optionally substituted in the 2-position by halogen or Ci-C ₄ alkyl. is also preferably a residue

in which

X is halogen, C 1 -C 4 -alkyl or C 1 -C -haloalkyl and

Y represents halogen, C 1 -C 4 -alkyl, C 1 -C 4 -haloalkyl, C 1 -C 4 -haloalkoxy, azido or cyano.

A is also preferably a radical from the series consisting of 5,6-difluoropyrid-3-yl, 5-chloro-6-fluoropyrid-3-yl, 5-bromo-6-fluoropyrid-3-yl, 5-iodo-6-fluoro-pyrid-3-yl, 5-fluoro-6-chloro-pyrid-3-yl, 5,6-dichloro-pyrid-3-yl, 5-bromo-6-chloro-pyrid 3-yl, 5-iodo-6-chloro-pyrid-3-yl, 5-fluoro-6-bromo-pyrid-3-yl, 5-chloro-6-bromo-pyrid-3-yl, 5,6- Dibromo-pyrid-3-yl, 5-iodo-6-bromo-pyrid-3-yl, 5-fluoro-6-iodo-pyrid-3-yl, 5-chloro-6-iodo-pyrid-3-yl, 5-Bromo-6-iodo-pyrid-3-yl, 5,6-diiodo-pyrid-3-yl, 5-methyl-6-fluoro-pyrid-3-yl, 5-methyl-6-chloro-pyridine 3-yl, 5-methyl-6-bromo-pyrid-3-yl, 5-methyl-6-iodo-pyrid-3-yl, 5-difluoromethyl-6-fluoro-pyrid-3-yl, 5-difluoromethyl 6-chloropyrid-3-yl, 5-difluoromethyl-6-bromopyrid-3-yl and 5- Difluoromethyl-6-iodo-pyrid-3-yl. is furthermore preferred for one

in which n is 2, 3 or 4 and Z is fluorine, chlorine or bromine. R ¹ is preferably 2,2,2-trifluoroethyl or 2,2-difluoroethyl.

R ² preferably represents in each case optionally fluorine-, chlorine- or bromine-substituted methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, cyclopropyl or cyclobutyl.

B is preferably -CR ³ R ⁴ - or -H ₂ C-CR ³ R ⁴ -, in which

R ³ and R ⁴ independently of one another represent hydrogen, in each case optionally substituted by halogen, in particular fluorine, substituted methyl, ethyl or Ca-Ce-cycloalkyl (in particular cyclopropyl) or for halogen, in particular fluorine, or for C 1 -C 4 -alkoxy-C C4-alkyl, in particular methoxymethyl, or

R ³ and R ⁴ together with the carbon atom to which they are attached form a 3- to 6-membered carbon ring.

The active compound combinations according to the invention preferably contain one or more and in particular one of the compounds of the formula (I) listed in the following table.

Among these compounds, particularly preferred is the compound of the following formula (1-4)

This compound of the formula (1-4) is always particularly preferred according to the invention. Therefore, mention of compounds of formula (I) or compounds of formulas (1-1) to (I-11) always implies that the compound of formula (1-4) is preferred.

The active compound combinations according to the invention also contain one or more compounds from the groups (1-1) to (1-29) described below and / or one or more compounds from the groups (Fl) to (F-14).

The active substances mentioned here with their "common name" are known and described, for example, in the Pesticide Handbook ("The Pesticide Manual" 14th Ed., British Crop Protection Council 2006) or searchable on the Internet (eg http://www.alanwood.net/pesticides ).

(1) Acetylcholinesterase (AChE) inhibitors, such as

Carbamates, e.g. Alanycarb, Aldicarb, Bendiocarb, Benfuracarb, Butocarboxime, Butoxycarboxime, Carbaryl, Carbofuran, Carbosulfan, Ethiofencarb, Fenobucarb, Formetanate, Furathiocarb, Isoprocarb, Methiocarb, Methomyl, Metolcarb, Oxamyl, Pirimicarb, Propoxur, Thiodicarb, Thiofanox, Triazamate, Trimethacarb, XMC and xylylcarb; or

Organophosphates, e.g. B. Acephate, Azamethiphos, Azinphos-ethyl, Azinophos-methyl, Cadusafos, Chloroethoxyfos, Chlorfenvinphos, Chlormephos, Chloφyrifos, Chlorpyrifos-methyl, Coumaphos, Cyanophos, Demeton-S-methyl, Diazinone, Dichlorvos / DDVP, Dicrotophos, Dimethoates, Dimethylvinphos, Disulfoton, EPN, Ethion, Ethoprophos, Famphur, Fenamiphos, Fenitrothion, Fenthion, Fosthiazate, Heptenophos, Imicyafos, Isofenphos, Isopropyl O- (methoxyaminothio-phosphoryl) salicylate, Isoxathione, Malathion, Mecarbam, Methamidophos, Methidathione, Mevinphos, Monocrotophos, Naled, Omethoate, Oxydemeton-methyl, Parathion, Parathion-methyl, Phenthoate, Phorate, Phosalone, Phosmet, Phosphamidon, Phoxim, Pirimiphos-methyl, Profenofos, Propetamphos, Prothiofos, Pyraclofos, Pyridaphenthion, Quinalphos, Sulfotep, Tebupirimfos, Temephos, Terbufos, Tetrachlorvinphos, Thiometon, Triazophos, triclorfone and vamidothion. (2) GABA-controlled chloride channel antagonists, such as

Cyclodiene organochlorines, e.g. Chlordane and endosulfan; or

Phenylpyrazoles (fiproles), e.g. Ethiprole and fipronil.

(3) Sodium channel modulators / voltage dependent sodium channel blockers, such as

Pyrethroids, eg acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin S-cyclopentenyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin , alpha-cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin [(lR) -trans isomers], deltamethrin, empenthrin [(EZ) - (IR) -isomers]], esfenvalerates, etofenprox, fenpropathrin, Fenvalerates, flucythrinates, flumethrin, tau-fluvalinates, halfenprox, imiprothrin, kadethrin, permethrin, phenothrin [(lR) -trans-isomer)], prallethrin, pyrethrins (pyrethrum), resmethrin, silafluofen, tefluthrin, tetramethrin, tetramethrin [(1R) - isomers)], tralomethrin and transfluthrin; or

DDT; or methoxychlor.

(4) nicotinergic acetylcholine receptor (nAChR) agonists such as neonicotinoids, e.g. Acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam; or

Nicotine.

(5) nicotinergic acetylcholine receptor (nAChR) allosteric activators such as spinosines, e.g. Spinetoram and spinosad. (6) chloride channel activators, such as

Avermectins / milbemycins, e.g. Abamectin, Emamectin benzoate, Lepimectin and Milbemectin. (7) juvenile hormone mimics, such as

Juvenile hormone analogs, e.g. Hydroprene, kinoprene and methoprene; or fenoxycarb; or pyriproxyfen. (8) agents with unknown or nonspecific modes of action, such as alkyl halides, e.g. Methyl bromide and other alkyl halides; or chloropicrin; or sulfuryl fluoride; or borax; or tartar emetic.

(9) Selective feeding inhibitors, e.g. pymetrozine; or flonicamide.

(10) mite growth inhibitors, e.g. Clofentezine, hexythiazox and diflovidazine; or Etoxazole.

(11) Microbial disruptors of the insect intestinal membrane, eg Bacillus thuringiensis subspecies israelensis, Bacillus sphaericus, Bacillus thuringiensis subspecies aizawai, Bacillus thuringiensis subspecies kurstaki, Bacillus thuringiensis subspecies tenebrionis and BT plant proteins: CrylAb, CrylAc, CrylFa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb, Cry34 / 35Abl.

(12) inhibitors of oxidative phosphorylation, ATP disruptors such as diafenthiuron; or organotin compounds, e.g. Azocyclotine, cyhexatin and fenbutatin oxide; or propargite; or tetradifon.

(13) Decoupling of oxidative phosphorylation by interruption of the H proton gradient, such as chlorfenapyr, DNOC, and sulfluramide.

(14) Nicotinergic acetylcholine receptor antagonists such as Bensultap, Cartap hydrochloride, thiocyclam and thiosultap sodium. (15) Type 0 inhibitors of chitin biosynthesis, such as bistrifluron, chlorofluorazuron, diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron and triflumuron.

(16) inhibitors of chitin biosynthesis, type 1, such as buprofezin.

(17) Moulting agents, dipteran, such as cyromazine. (18) ecdysone receptor agonists, such as chromafenozides, halofenozides, methoxyfenozides, and tebufenozides.

(19) Octopaminergic agonists, such as amitraz.

(20) complex III electron transport inhibitors such as hydramethylnone; or acequinocyl; or fluacrypyrim. (21) Complex I electron transport inhibitors, for example

METI acaricides, e.g. Fenazaquin, Fenpyroximate, Pyrimidifen, Pyridaben, Tebufenpyrad and Tolfenpyrad; or

Rotenone (Derris).

(22) voltage-dependent sodium channel blockers, eg indoxacarb; or metafionizone. (23) inhibitors of acetyl-CoA carboxylase, such as

Tetronic and tetramic acid derivatives, e.g. Spirodiclofen, spiromesifen and spirotetramat.

(24) complex IV electron transport inhibitors such as

Phosphines, e.g. Aluminum phosphide, calcium phosphide, phosphine and zinc phosphide; or cyanide.

(25) Complex II electron transport inhibitors, such as cyenopyrafen.

(28) ryanodine receptor effectors such as diamides, e.g. Chlorantraniliprole and flubendiamide.

(29) Other active substances such as amidoflumet, azadirachtin, benclothiaz, benzoximate, bifenazate, bromopropylate, quinomethionate, cryolite, cyantraniliprole (cyazypyr), cyflumetofen, dicofol,

Diflovidazine, fluensulfones, flufenerim, flufiprole, fluopyram, fufenocide, imidaclothiz, iprodione, meperfluthrin, pyralidyl, pyrifluquinazone, tetramethylfluthrin and iodomethane; furthermore preparations based on Bacillus firmus (in particular strain CNCM 1-1582, for example VOTiVO ™, BioNem) and the following compounds: 3-bromo-N- {2-bromo-4-chloro-6 - [(1-cyclopropylmethyl) carbamoyl] phenyl} -1- (3-chloropyridin-2-yl) -1H-pyrazole-5-carboxamide (known from WO2005 / 077934), 4 - {[(6-bromopyrid-3-yl) memyl] (2-fluoromyl) amino} furan-2 (5H) -one (known from WO2007 / 1 15644), 4 - {[(6-fluoro-3-yl) -methyl] (2,2-difluoroethyl) amino} furan-2 (5H) -on (known from WO2007 / 1 15644), 4 - {[(2-chloro-1,3-miazol-5-yl) -memyl] (2-fluoro-amino) -amino} -furan-2 (5H) -o ^ (known from WO2007 / 115644), 4 - {[(6-chloro-3-yl) methyl] (2-fluoro-amino) -amino} furan-2 (5H) -one (known from WO2007 / 115644), Flupyradifurone, 4- {[(6-chloro-5-fluoro-3-yl) -memyl] (memyl) amino} furan-2 (5H) -one (known from WO2007 / 1 15643), 4 - {[(5,6-dichloro yrid-3-yl) me l] (2-fluoromyl) amino} furan-2 (5H) -one (known from WO2007 / 1 15646), 4 - {[(6-chloro-5-fluoropyrid-3-yl ) memyl] (cyclopropyl) amino} furan-2 (5H) -one (known from WO2007 / 115643), 4 - {[(6-chloropyrid-3-yl) me myl] (cyclopropyl) amino} furan-2 (5H) -one (known from EP-A-0 539 588), 4 - {[(6-chloro-3-yl) methyl] (methyl) amino} furan -2 (5H) -one (known from EP-A-0 539 588), {[1- (6-chloropyridin-3-yl) ethyl] (methyl) oxido-λ ⁴ -sulfanylidene} cyanamide (known from WO2007 / 149134) and its diastereomers {[(IR) -l- (6-chloro-pyridin-3-yl) -ethyl] (methyl) -oxo- ⁴ -sulfanylidene} -cyanamide (A) and {[(IS) -l- (6 Chloφyridin-3-yl) ethyl] (methyl) oxido-λ ⁴ -sulfanylidene} cyanamide (B) (also known from WO2007 / 149134) as well as sulfoxaflor and its diastereomers [(R) -maryl (oxido) {(IR) -l - [6- (trifluoromethyl) pyridm ^ (AI) and [(S) - Methyl (oxido) {(1 S) - 1 - [6- (trifluoromethyl) pyridin-3-yl] ethyl} - ⁴ -sulfanyliden] cyanamide (A2), referred al s Diastereomerengruppe A (known from WO 2010/074747, WO 2010/074751), [(R) methyl (oxido) {(lS) -l- [6- (trifluoromethyl) pyridin-3-yl] ethyl} - ⁴ -sulfanyliden] cyanamide (Bl) and [(S) - methyl (oxido) {(lR) -l- [6- (trifluoromethyl) pyridin-3-yl] ethyl} - ⁴ -sulfanyliden] cyanamide (B2), referred to as Diastereomerengruppe B (also known from WO 2010/074747, WO 2010 No. 074751) and 1-l- (4-chloro-2,6-dimethylphenyl) -12-hydroxy-1,4-dioxa-9-azadispiro [4.2.4.2] tetradec-11-en-10-one (known from US Pat WO2006 / 089633), 3- (4'-fluoro-2,4-dimethylbiphenyl-3-yl) -4-hydroxy-8-oxa-1-azaspiro [4.5] dec-3-en-2-one (known from WO2008 / 067911), 1- {2-fluoro-4-methyl-5 - [(2,2,2-trifluoremyl) sulfinyl] phenyl} -3- (trifluoromethyl) -1H (known from WO2006 / 043635), 3S, 4aR, 12R, 12aS, 12bS) -3 - [(Cyclopropylcarbonyl) oxy] -6,12-dihydroxy-4,12b-dimethyl-11-oxo-9- (pyridin-3-yl) -1, 3 , 4,4a, 5,6,6a, 12, 12a, 12b-decahydro-2H, 1 lH-ben zo [f] pyrano [4,3-b] chromen-4-yl] methylcyclopropanecarboxylate (known from WO2008 / 066153), 2-cyano-3- (difluoromethoxy) - Ν, Ν-dimethylbenzene sulfonamide (known from WO2006 / 056433), 2- Cyan-3- (difluoromethoxy) -N-methylbenzenesulfonamide (known from WO2006 / 100288), 2-cyano-3- (difluoromethoxy) -N-ethylbenzenesulfonamide (known from WO2005 / 035486), 4- (difluoromethoxy) -N-ethyl- N-methyl-1,2-benzothiazol-3-amine-1,1-dioxide (known from WO2007 / 057407), N- [1- (2,3-dimethylphenyl) -2- (3,5-dimethylphenyl) ethyl ] 4,5-dihydro-l, 3-thiazol-2-amine (known from WO2008 / 104503), {1 '- [(2E) -3- (4-chlorophenyl) -prop-2-en-1-yl ] -5-fluorospiro [indole-3, 4'-piperidine] -1 (2H) -yl} (2-chloropyridin-4-yl) methanone (known from WO2003 / 106457), 3- (2,5-dimethylphenyl) 4-hydroxy-8-methoxy-l, 8-diazaspiro [4.5] dec-3-en-2-one (known from WO2009 / 049851), 3- (2,5-dimethylphenyl) -8-methoxy-2- oxo-l, 8-diazaspiro [4.5] dec-3-en-4-yl-ethyl carbonate (known from WO2009 / 049851), 4- (but-2-yn-1-yloxy) -6- (3,5 -dimethylpiperidin-1-yl) -5-fluorop yrimi din (b ek accepts WO 2004/099 1 60), (2, 2, 3, 3, 4, 4, 5, 5-octafluoropentyl) (3,3,3-trifluoropropyl) malononitrile (known from WO2005 / 063094), (2,2,3,3,4,4,5,5-octafluc-butyl) (3,3,4,4,4-pentafluorobutyl) malononitrile (known from WO2005 / 063094), 8- [2 - (Cyclopropylmethoxy) -4- (trifluoromethyl) phenoxy] -3- [6- (trifluoromethyl) pyridazin-3-yl] -3-azabital] octane (known from WO2007 / 040280), Flometoquine, PF1364 (CAS Reg. No. No. 1204776-60-2) (known from JP2010 / 018586), 5- [5- (3,5-dichloro-phenyl) -5- (trifluoromethyl) -4,5-dihydro-1,2-oxazol-3-yl] - 2- (1H-1,2,4-triazol-1-yl) benzonitrile (known from WO2007 / 075459), 5- [5- (2-chloro-4-yl) -5- (trifluoromethyl) -4 , 5-dihydro-l, 2-oxazol-3-yl] -2- (1H-l, 2,4-triazol-1-yl) benzonitrile (known from WO2007 / 075459), 4- [5- (3,5-Dichloro-phenyl) -5- (trifluoromethyl) -4,5-dihydro-1,2-oxazol-3-yl] -2-methyl-N- {2-oxo-2 - [(2,2, 2-trifluoroethyl) amino] ethyl} benzamide (known from WO2005 / 085216),

yl) methyl] (cyclopropyl) amino} -1,3-oxazol-2 (5H) -one, 4 - {[(6-chloropyridin-3-yl) methyl] (2,2-difluoroethyl) amino} -1, 3-oxazol-2 (5H) -one, 4- {[(6-chloropyridin-3-yl) methyl] (ethyl) amino} -1,3-oxazol-2 (5H) -one, 4 - {[( 6-chloro-pyridin-3-yl) -methyl] (methyl) -amino} -l, 3-oxazol-2 (5H) -one (all known from WO2010 / 005692), NNI-0711 (known from WO2002 / 096882), acetyl-N- [4- (l, l, l, 3,3,3-hexafluoro-2- methoxypropan-2-yl) -3-isobutylphenyl] -N-isobutyryl-3,5-dimethyl-1H-pyrazole-4-carboxylic acid oxami d (b ek taken from WO2002 / 096882), methyl 2- [2 - ({[3-bromo-1- (3-chloropyridin-2-yl) -1H-pyrazol-5-yl] carbonyl} amino) -5-chloro-3-methylbenzoyl] -2-methylhydrazinecarboxylate (known from WO2005 / 085216), methyl 2- [2 - ({[3-bromo-1- (3-chloro-pyridin-2-yl) -1H-pyrazol-5-yl] -carbonyl} -amino) -5-cyano-3-m

(known from WO2005 / 085216), methyl 2- [2 - ({[3-bromo-1- (3-chloro-2-yl) -1H-pyrazol-5-yl] carbonyl} amino) -5 -cyan-3-methylbenzoyl] -2-methylhydrazinecarboxylate (known from WO2005 / 085216), methyl 2- [3,5-dibromo-2 - ({[3-bromo-1- (3-chloropyridin-2-yl) -lH yrazol-5-yl] carbonyl} amino) benzoyl] -1,2-diethylhydrazinecarboxylate (known from WO2005 / 085216), methyl 2- [3,5-dibromo-2 - ({[3-bromo-1-yl] (3-Chloro-2-yl) -1-yl-yl] carbonyl} amino) benzoyl] -2-ethylhydrazinecarboxylate (known from WO2005 / 085216), (5RS, 7RS; 5RS, 7SR) -l- (6 chloro-3-pyridylme ^

5 ropoxyimidazo [1,2-a] pyridine (known from WO2007 / 101369), 2- {6- [2- (5-Ρ1υοφ> τϊ (1ϊη-3 ^ 1) -1,3-11ιΪ3ζο1-5-yl] pyridin-2-yl} pyrimidine (known from WO2010 / 006713), 2- {6- [2- (pyridin-3-yl) -l, 3-thiazol-5-yl] pyridin-2-yl] pyrimidine (known from WO2010 / 00671 3), 1- (3-chloro-2-yl) -N- [4-cyano-2-methyl-6- (methylcarbamoyl) phenyl] -3 - {[5 - ( trifluoromethyl) -1-H-tetrazol-1-yl] methyl} -1-H-pyrazole-5-carboxamide (known from WO2010 / 069502), 1- (3-chloro-2-yl) -N- [4-cyano 2-methyl-6- (methylcarbamoyl) phenyl] -3- {[5- (trifluoromethylene) -2H-tetrazol-2-yl] methyl} -1H-pyrazole-5-carboxamide (known from WO2010 / 069502), N- [2- (tert-butylcarbamoyl) cyan-6-methylpheny

1-yl] methyl} -1H-pyrazole-5-carboxamide (known from WO2010 / 069502), N- [2- (tert-butylcarbamoyl) -4-cyano-6-methylphenyl] -1- (3-chloridrid -2-yl) -3 - {[5- (trifluoromethyl) -2H-tetrazol-2-yl] methyl} -1 H -pyrazole-5-carboxamide (known from WO2010 / 069502), N- [2- (5 -Amino-l, 3,4-thiadiazol-2-yl) -4-chloro-6-methylphenyl] -3-bromo-1- (3-chloropyridin-2-yl) -1H-pyrazole-5-carboxamide (known from CN102057925) and methyl 2- [3,5-dibromo-2 - ({[3-bromo-1- (3-chloro-2-yl) -1-yhyrazol-5-yl] carbonyl} amino) benzoyl] 2-ethyl-1-methylhydrazinecarboxylate (known from WO2011 / 049233).

(F-1) inhibitors of nucleic acid synthesis such as benalaxyl, benalaxyl-M, bupirimate, clozylacone, dimethirimol, ethirimol, furalaxyl, hymexazole, metalaxyl, metalaxyl-M, ofurace, oxadixyl and oxolic acid.

(F-2) Inhibitors of mitosis and cell division, such as benomyl, carbendazim, chlorfenazole, diethofencarb, ethaboxam, fuberidazole, pencycuron, thiabendazole, thiophanate, thiophanate-methyl and zoxamide. (F-3) inhibitors of respiration (respiratory chain inhibitors), such as diflumetorim as an inhibitor at complex I of the respiratory chain; Bixafen, boscalid, carboxin, fenfuram, flutolanil, fluopyram, furametpyr, furmecyclox, isopyrazam (mixture of the sy-epimeric racemate \ RS, 4SR, 9RS and the ßwft ^'epimers racemate IRS, 4SR, 9SR) Isopyrazam (sy "-epimeres racemate IRS, 4SR, 9RS) Isopyrazam (syn epimeric enantiomer 1R, 4S, 9R), Isopyrazam (sy" -epimeres enantiomer \ S, 4 R , 9S), isopyrazam (anti- epimeric racemate \ RS, 4SR, 9SR), isopyrazam (awfr ^' epimeric enantiomer \ R, 4S, 9S), isopyrazam (anti- epimeric enantiomer \ S, 4R, 9R), mepronil, oxycarboxin , Penflufen, Penthiopyrad, Sedaxane, thifluzamide as inhibitors of complex II of the respiratory chain; Amisulbrom, azoxystrobin, cyazofamide, dimoxystrobin, enestroburin, famoxadone, fenamidone, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin, picoxystrobin,

Pyraclostrobin, Pyraoxystrobin, Pyrametostrobin, Pyribencarb, Trifloxystrobin as inhibitors of the complex III of the respiratory chain. (F-4) decouplers such as binapacryl, dinocap, fluazinam and meptyldinocap.

(F-5) Inhibitors of ATP Production, such as Fentin Acetate, Fentin Chloride, Fentin Hydroxide and Silthiofam.

(F-6) Inhibitors of amino acid and protein biosynthesis, such as andoprim, blasticidin-S ', cyprodinil, kasugamycin, kasugamycin hydrochloride hydrate, mepanipyrim and pyrimethanil. (F-7) signal transduction inhibitors such as fenpiclonil, fludioxonil, fluxapyroxad and quinoxyfen.

(F-8) Inhibitors of lipid and membrane synthesis, such as biphenyl, chlozolinate, edifenphos, etridiazole, iodocarb, Iprobenfos, iprodione, isoprothiolane, procymidone, propamocarb, propamocarb hydrochloride, pyrazophos, tolclofos-methyl and vinclozolin. (F-9) inhibitors of ergosterol biosynthesis, such as aldimorph, azaconazole, bitertanol, bromuconazole, cyproconazole, diclobutrazole, difenoconazole, diniconazole, diniconazole-M, dodemorph, dodemorph acetate, epoxiconazole, etaconazole, fenarimol, fenbuconazole, fenhexamide, fenpropidin, Fenpropimorph, fluquinconazole, flurprimidol, flusilazole, flutriafol, furconazole, furconazole cis, hexaconazole, imazalil, imazalil sulfate, imibenconazole, ipconazole, metconazole, myclobutanil, naftifine, nuarimol, oxpoconazole, paclobutrazole, pefurazoate, penconazole, piperaline, prochloraz, propiconazole, prothioconazole , Pyributicarb, Pyrifenox, Quinconazole, Simeconazole, Spiroxamine, Tebuconazole, Terbinafine, Tetraconazole, Triadimefon, Triadimenol, Tridemorph, Triflumizol, Triforin, Triticonazole, Uniconazole, Viniconazole and Voriconazole. (F-10) inhibitors of cell wall synthesis, such as benthiavalicarb, dimethomo h, flumo h, iprovalicarb, mandipropamide, polyoxins, polyoxorim, prothiocarb, validamycin A and valefenalate.

(F-1) Inhibitors of melanin biosynthesis, such as carpropamide, diclocymet, fenoxanil, fthalide, pyroquilone and tricyclazole. (F-12) resistance inducers such as acibenzolar-S-methyl, probenazole and tiadinil.

(F-13) compounds with multisite activity, such as Bordeaux mixture, captafol, captan, chlorothalonil, copper naphthenate, copper oxide, copper oxychloride, copper preparations, such as copper hydroxide, copper sulfate, dichlofluanid, dithianone, dodine and its free base, Ferbam, Fluorofolpet, Folpet, Guazatine, guazatine acetate, iminoctadine, iminoctadinal besylate, iminoctadine triacetate, mancopper, mancozeb, maneb, metiram, zinc metiram, copper oxine, propamidine, propineb, sulfur and sulfur preparations such as calcium polysulfide, thiram, tolylfluanid, zineb and ziram.

(F-14) Other compounds such as 2,3-dibutyl-6-chlorothieno [2,3-d] pyrimidin-4 (3H) -one, (2Z) -3-amino-2-cyano-3-phenylprop -2-enoic acid ethyl ester, N- [2- (1, 3-dimethylbutyl) phenyl] -5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide, 3- (difluoromethyl) -1-methyl-N- (3 ', 4', 5'-trifluorobiphenyl-2-yl) -1H-pyrazole-4-carboxamide, 3- (difluoromethyl) -N- [4-fluoro-2- (1,1,3,3,3 , 3-hexafluoropoxy) phenyl] -1-methyl-1H-pyrazole-4-carboxamide, (2E) -2- (2 - {[6- (3-chloro-2-methylphenoxy) -5-fluoro-pyrimidine 4-yl] oxy} phenyl) -2- (methoxyimino) -N-methylethaneamide, (2iT) -2- {2 - [({[(2 £ ^' , 3 £ ^, ) -4- (2,6-dichlorophenyl) but-3-en-2-ylidene] amino} oxy) methyl] phenyl} -2- (methoxyimino) -N-methylethanamide, 2-chloro-N- (1,1,3-trimethyl-2,3-dihydroxy) 1H-inden-4-yl) pyridine-3-carboxamide, N- (3-ethyl-3,5,5-trimethylcyclohexyl) -3- (formylamino) -2-hydroxybenzamide, 5-methoxy-2-methyl-4- (2- {[({(l) -l- [3- (trifluoromethyl) phenyl] -emylidene} amino) oxy] -methyl} -phenyl) -2,4-dihydro-3H-l, 2,4-triazole ^ n , (2E) -2 (Methoxyimino) -N-methyl-2- (2- {[({(IE) -1- [3 - (trifluoromethyl) phenyl] ethylidene} amino) oxy] methyl} phenyl) ethanamide, (2i?) -2- (Memoxyimino) -N-memyl-2- {2- [i? - ({1- [3- (trifluoromethyl) phenyl] ethoxy} imino) methyl] phenyl} ethanamide, (2E) -2- {2 - [({[(liT) -l- (3 - {[(£ ^, ) -1-fluoro-2-phenylethenyl] oxy} phenyl) ethylidene] amino} oxy) methyl] phenyl} -2- (methoxyimino) -N-methylethaneamide, 1- (4-chloro-1-yl) -2- (1H-1,2,4-triazole-1-l) -cycloheptanol, 1 - (2,2-dimethyl-1, 2, 3 - dihydro-1H-inden-1-yl) - 1H-imidazole-5-carboxylic acid methyl ester, N-ethyl-N-methyl- N '- {2-methyl-5 - (trifluoromethyl) -4- [3 -

(trimethylsilyl) propoxy] phenyl} imidoformamide, N '- {5- (difluoromethyl) -2-methyl-4- [3 - (trimethylsilyl) propoxy] phenyl} -N-ethyl-N-methylimidoformamide, 0- {l - [(4-methoxyphenoxy) methyl] -2,2-dimethylpropyl} -1H-imidazole-1-carbothioate, N- [2- (4 - {[3- (4-chlorophenyl) -prop-2-yn-1-yl ] oxy} -3-methoxyphenyl) ethyl] -N ² - (methylsulfonyl) valinamide, 5-chloro-7- (4-methylpiperidin-1-yl) -6- (2,4,6-trifluorophenyl) [1, 2 , 4] triazolo [1,5-a] pyrimidine, 5-amino-1,3,3,4-thiadiazole-2-thiol, propamocarb-fosetyl, 1 - [(4-methoxyphenoxy) methyl] -2,2-dimethylpropyl 1H-imidazole-1-carboxylate, 1-methyl-N- [2- (1,1,2,2-tetrafluoroethoxy) phenyl] -3- (trifluoromethyl) -LH-pyrazole-4-carboxamide, 2,3,5,6-tetrachloro-4- (methylsulfonyl) pyridine, 2-butoxy-6-iodo-3-propyl-4H-chromen-4-one, 2-phenylphenol and its salts, 3- (difluoromethyl) -1-methyl-N- [2- (1,1,2,2-tetrafluoroethoxy) phenyl] -1H-pyrazole-4-carboxamide, 3, 4.5 -

Trichloride-2,6-dicarbonitrile, 3 - [5 - (4-chloro-phenyl) -2,3-dimethyl-isoxazolidin-3-yl-pyridine, 3-chloro-5 - (4-chloro-4-yl) -4- (2,6- difluo-henyl) -6-mypropyridazine, 4- (4-ηηοοηη 6 ^ 1) -5- (2,6, γ, ιιτιιθφηη), 6-dimethylpyridazine, 8-hydroxyquinoline, 8-hydroxyquinoline sulfate, tebufloquine, 5- Methyl 6-octyl-3,7-dihydro [l, 2,4] triazolo [l, 5-a] pyrimidin-7-amine, 5-ethyl-6-octyl-3,7-dihydro [l, 2, 4] triazolo [l, 5-a] pyrimidine-7-amine, ametoctradine, benthiazole, bethoxazine, capsimycin, carvone, quinomethionate, chloroneb, cufraneb, cyflufenamid, cymoxanil, cyprosulfamide, dazomet, debacarb, dichlorophen, diclomethine, dicloran, difenzoquat, Difenzoquat Methylsulphate, Diphenylamine, Ecomat, Ferimzone, Flumetover, Fluopicolide, Fluoromide, Flusulfamide, Flutianil, Fosetyl-aluminum, Fosetyl-calcium, Fosetyl-sodium, H exachlorobenzene, Irum amy c in, I s oti anil, Meth asul fo c arb, (2iT) -2- {2 - [({cyclopropyl [(4-methoxyphenyl) imino] memyl} thio) memyl] phenyl} -3-methoxyacrylsaeuromethyl esters,

Methyl isothiocyanate, metrafenone, (5-chloro-2-methoxy-4-methylpyridin-3-yl) (2,3,4-trimethoxy-6-methylphenyl) methanone, mildiomycin, tolnifanide, N- (4-chlorobenzyl) -3- [3-methoxy-4- (prop-2-yn-1-yloxy) phenyl] propanamide, N - [(4-chlorophenyl) (cyano) methyl] -3- [3-methoxy-4- (prop-2- yn-1-yloxy) phenyl] propanamide, N- [(5-bromo-3-chloropyridin-2-yl) methyl] -2,4-dichloro-pyridine-3-carboxamide, N- [1- (5-bromo-3 -chloropyridin-2-yl) ethyl] -2,4-dichloro-pyridine-3-carboxamide, N- [1- (5-bromo-3-chloro-2-yl) ethyl] -2-fluoro-4-iodo-pyridine 3-carboxamide, N - {(Z) - [(cyclopropylmethoxy) imino] [6- (difluoromethoxy) -2,3-difluorophenyl] methyl} -2-phenylacetamide, N - {(iT) - [(cyclopropylmethoxy) imino ] [6- (difluoromethoxy) -2,3-difluorophenyl] methyl} -2-phenylacetamide, natamycin, nickel dimethyldithiocarbamate, nitrothal-isopropyl, octhilinones, oxamocarb, oxyfenthiine, pentachlorophenol and its salts, phenazine-1-carboxylic acid, phenothrin, phosphoric acid and their salts, propamocarb fosetylate, propanosine sodium, Proquinazide, pyrroline nitrite, quintozene, S-prop-2-en-1-yl 5-amino-2- (1-methylethyl) -4- (2-methylphenyl) -3-oxo-2,3-dihydro-1H-pyrazole -l-carbothioate, Tecloftalam, Tecnazene, triazoxide, trichlamide, 5-chloro-N'-phenyl-N'-prop-2-yn-1-ylthiophene-2-sulfonohydrazide, zarilamide, N-methyl-2- (l- {[5-methyl-3- (trifluoromethyl) -1-pyrazol-1-yl] -acetyl} -piperidin-4-yl) -N - [(1R) -1,2,3,4-tetrahydronaphthalene-1-yl] - 1, 3 -thiazole-4-carboxamide, N-methyl-2- (1 - {[5-methyl-3 - (trifluoromethyl) -1H-pyrazol-1-yl] -acetyl} -piperidin-4-yl) -N - (1, 2,3, 4-tetrahydronaphthalen-1-yl) -1, 3-thiazole-4-carboxamide, 3- (difluoromethyl) -N- [4-fluoro-2- (1, 1, 2.3 , 3,3-hexafluoropropoxy) phenyl] -1-methyl-1H-pyrazole-4-carboxamide and pentyl {6 - [({[(1-methyl-1H-tetrazol-5-yl) (phenyl) methylidene] -amino } oxy) methyl] pyridin-2-yl} carbamate.

Preferred compounds from these groups are: Acrinathrin, alpha-cypermethrin, beta-cyfluthrin, cyhalothrin, cypermethrin, deltamethrin

Esfenvalerate, etofenprox, fenpropathrin, fenvalerate, flucythrinate, lambda-cyhalothrin, gamma-cyhalothrin, permethrin, tau-fluvalinate, transfluthrin, zeta-cypermethrin, cyfluthrin, bifenthrin, tefluthrin, eflusilanate, fubfenprox, pyrethrin, resmethrin, imidacloprid, acetamiprid, thiamethoxam, Nitenpyram, thiacloprid, dinotefuran, clothianidin, imidaclothiz, chlorofluorazuron, diflubenzuron, lufenuron, teflubenzuron, triflumuron, novaluron, flufenoxuron, hexaflumuron, bistrifluorone, noviflumuron, buprofezin, cyromazine, methoxyfenozide, tebufenozide, halofenozide, chromafenozide, endosulfan, fipronil, ethiprole, pyrafluprole, Pyriprole, flubendiamide, chlorantraniliprole (rynaxypyr), cyantraniliprole (cyazypyr), emamectin, emamectin benzoate, abamectin, ivermectin, milbemectin, lepimectin, tebufenpyrad, fenpyroximate, pyridaben, fenazaquin, pyrimidifen, tolfenpyrad, dicofol, cyenopyrafen, cyflumetofen, acequinocyl, fluacrypyrin, bifenazate , Diafenthiuron, etoxazole, clofentezine, spinosad, Triarathene, tetradifon, propargite, hexythiazox, bromopropylate, quinomethionate, amitraz, pyrifluquinazone, pymetrozine, flonicamid, pyriproxyfen, diofenolan, chlorfenapyr, metaflumizone, indoxacarb, chlorpyrifos, spirodiclofen, spiromesifen, spirotetramat, pyridalyl, spinetoram, acephate, triazophos, profenofos, fenamiphos, 4- {[(6-Chloropyrid-3-yl) methyl] (2,2-difluoroethyl) amino} furan-2 (5H) -one, cadusaphos, carbaryl, carbofuran, ethoprophos, thiodicarb, aldicarb, metamidophos, methiocarb, sulfoxaflor ,

Preferred compounds from these groups are furthermore:

Azoxystrobin, Boscalid, Penflufen, Bixafen, Fluopyram, Carpropamid, Spiroxamine, Fluxapyroxad, Carbendazim, Carboxin, Fenamidone, Fludioxonil, Fluopicolide, Fluoxastrobin, Fluquinconazole, Flutriafol, Ipconazole, Iprodione, Isotianil, Mefenoxam, Metalaxyl, Metominostrobin, Pencycuron, Prochloraz, Prothioconazole, Pyraclostrobin, Pyrimethanil, Sedaxane, Silthiopham, Tebuconazole, Thiram, Tolylfluanid, Triadimenol, Triazoxide, Trifloxystrobin, Triflumuron and Triticonazole.

Preference is given to those active compound combinations in which a compound of the formula (I) is combined with the compounds Nos. 1 to 150 given in Table A. The preferred, particularly preferred and most preferred mixing ratios given in the table are weight ratios. The ratio is to be understood in each case as compound of the formula (I) for Mischpartner Nr.1 to 150. Table A:

No. Mischpartner preferred particularly preferred especially

Mixing ratio mixing ratio preferred

mixing ratio

1. Acrinathrin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

2. Alpha-Cypermethrin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

3. Beta-Cyfluthrin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

4. Cyhalothrin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

5. Cypermethrin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

6. Deltamethrin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

7. Esfenvalerate 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

8. Etofenprox 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

9. Fenpropathrin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

10. Fenvalerate 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

11. Flucythrinate 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

12.a Lambda Cyhalothrin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

12.b gamma-cyhalothrin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

13. Permethrin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

14. Tau fluvalinate 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

15. Transfluthrin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

16. Zeta-Cypermethrin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

17. Cyfluthrin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

18. Bifenthrin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

19. Tefluthrin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

20. Eflusilanate 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

21. Fubprox 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

22. Pyrethrin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

23. Resmethrin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

24. Imidacloprid 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

25. Acetamiprid 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

26. Thiamethoxam 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

27. Nitenpyram 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

28. Thiacloprid 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

29. Dinotefuran 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5 No. Mischpartner preferred particularly preferred especially

Mixing ratio mixing ratio preferred

mixing ratio

30. Clothianidin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

31. Imidaclothiz 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

32. Chlorofluorazuron 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

33. Diflubenzuron 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

34. Lufenuron 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

35. Teflubenzuron 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

36. Triflumuron 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

37. Novaluron 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

38. Flufenoxuron 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

39. Hexaflumuron 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

40. Bistrifluorone 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

41. Noviflumuron 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

42. Buprofezin 625: 1 to 1: 625 125: 1 to 1: 125 25: 1 to 1:25

43. Cyromazine 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

44. Methoxyfenozides 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

45. Tebufenozide 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

46. Halofenocides 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

47. Chromafenozides 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

48. Endosulfan 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

49. Fipronil 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

50. Ethiprole 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

51. Pyrafluproles 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

52. Pyriproles 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

53. Flubendiamide 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

54. Chlorantraniliproles 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

(Rynaxypyr)

55. Cyantraniliproles 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

(Cyazypyr)

56. Emamectin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

57. Emamectin benzoate 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

58. Abamectin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

59. Ivermectin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5 No. Mischpartner preferred particularly preferred especially

Mixing ratio mixing ratio preferred

mixing ratio

60. Milbemectin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

61. Lepimectin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

62. Tebufenpyrad 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

63. Fenpyroximate 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

64. Pyridene 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

65. Fenazaquin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

66. Pyrimidifen 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

67. Tolfenpyrade 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

68. Dicofol 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

69. Cyenopyrafen 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

70. Cyflumetofen 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

71. Acequinocyl 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

72. Fluacrypyrin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

73. Bifenazate 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

74. Diafenthiuron 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

75. Etoxazoles 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

76. Clofentezine 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

77. Spinosad 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

78. Triarythene 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

79. Tetradiflon 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

80. Propargite 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

81. Hexythiazox 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

82. Bromopropylate 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

83. Quinomethionate 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

84. Amitraz 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

85. Pyrifluoroquinones 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

86. Pymetrozine 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

87. Flonicamide 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

88. Pyriproxyfen 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

89. Diofenolane 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

90. Chlorfenapyr 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5 No. Mischpartner preferred particularly preferred especially

Mixing ratio mixing ratio preferred

mixing ratio

91. Metaflumizone 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

92. Indoxacarb 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

93. Chlorpyrifos 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

94. Spirodiclofen 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

95. Spiromesifen 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

96. Spirotetramat 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

97. Pyralidyl 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

98. Spinetoram 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

99. Acephates 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

100. Triazophos 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

101. Profenofos 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

102. Fenamiphos 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

103. 1 - [2-Fluoro-4-methyl-5 - 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

[(2,2,2-trifluoroethyl)

sulfinyl] phenyl] -3- (trifluoromethyl) -1H-1,2,4-triazole-5-amine

104. Bacillus firmus 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

105. Mixture of 1- (3-125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

Chloropyridinyl) -N- [4-cyano-2-methyl-6- [(methylamino)

carbonyl] phenyl] -3 - [[5- (trifluoromethyl) -2H-tetrazol-2-yl] methyl] -1H-pyrazole-5-carboxamide

and 1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl-6 [(methylamino)

carbonyl] phenyl] -3 - [[5

(trifluoromethyl) -1H-tetrazol-1-yl] methyl] -1H-pyrazole-5-carboxamide

106. 4 - {[(6-Chloropyrid-3-125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

yl) methyl] (2,2-difluoroethyl) amino} furan-2 (5H) -one

(Flupyradifurone)

107. Cadusaphos 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5 No. Mischpartner preferred particularly preferred especially

Mixing ratio mixing ratio preferred

mixing ratio

108. Carbaryl 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

109. Carbofuran 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

110. Ethoprophos 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

111. Thiodicarb 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

112. Aldicarb 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

113. Metamidophos 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

114. Methiocarb 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

115. Sulfoxaflor 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

116. Azoxystrobin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

117. Boscalid 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

118. Penetration 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

119. Carbendazim 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

120. Carboxin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

121. Fenamidone 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

122. Fludioxonil 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

123. Fluopicolides 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

124. Fluoxastrobin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

125. Fluquinconazole 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

126. Flutriafol 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

127. Ipconazole 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

128. Iprodione 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

129. Isotianil 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

130. Mefenoxam 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

131. Metalaxyl 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

132. Metominostrobin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

133. Pencycuron 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

134. Prochlorazole 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

135. Prothioconazole 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

136. Pyraclostrobin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

137. Pyrimethanil 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

138. Sedaxane 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5 No. Mischpartner preferred particularly preferred especially

Mixing ratio mixing ratio preferred

mixing ratio

139. Silthiopham 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

140. Tebuconazole 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

141. Thiram 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

142. Tolylfluanid 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

143. Triadimenol 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

144. Triazoxide 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

145. Trifloxystrobin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

146. Triflumuron 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

147. Triticonazole 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

148. Azadirachtin 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

149. Fluene sulfones 2000: 1 to 1: 2000 1250: 1 to 1: 1250 250: 1 to 1: 250

150. Pyrethrum 125: 1 to 1: 125 25: 1 to 1:25 5: 1 to 1: 5

The mixture listed in No.105 in the above table is preferably in a ratio of from 85:15 to 97: 3 for the first to the second named compound, these corner points being included. A preferred embodiment of the present invention relates to active ingredient combinations in which the compound of the formula (1-1) is present and as mixing partner of one of the abovementioned mixing partners of the numbers 1 to 150, wherein the preferred, particularly preferred and very particularly preferred mixing ratios as indicated above are.

A further preferred embodiment of the present invention relates to active ingredient combinations in which the compound of the formula (1-2) is present and as mixing partners of one of the abovementioned mixing partners of the numbers 1 to 150, wherein the preferred, particularly preferred and very particularly preferred mixing ratios as above are indicated.

A further preferred embodiment of the present invention relates to active ingredient combinations in which the compound of the formula (1-3) is present and as mixing partner of one of the abovementioned mixing partners of the numbers 1 to 150, wherein the preferred, particularly preferred and very particularly preferred mixing ratios as above are indicated.

Another particularly preferred embodiment of the present invention relates Active ingredient combinations in which the compound of the formula (1-4) is present and as a mixing partner of one of the abovementioned mixing partners of the numbers 1 to 150, wherein the preferred, particularly preferred and very particularly preferred mixing ratios are as indicated above.

A further preferred embodiment of the present invention relates to active ingredient combinations in which the compound of the formula (1-5) is present and as mixing partners of one of the abovementioned mixing partners of the numbers 1 to 150, wherein the preferred, particularly preferred and most particularly preferred mixing ratios as above are indicated.

A further preferred embodiment of the present invention relates to active ingredient combinations in which the compound of the formula (1-6) is present and as mixing partner of one of the abovementioned mixing partners of the numbers 1 to 150, wherein the preferred, particularly preferred and most particularly preferred mixing ratios as above are indicated.

A further preferred embodiment of the present invention relates to active ingredient combinations in which the compound of the formula (1-7) is present and as a mixing partner of one of the abovementioned mixing partners of the numbers 1 to 150, wherein the preferred, particularly preferred and very particularly preferred mixing ratios as above are indicated.

A further preferred embodiment of the present invention relates to active ingredient combinations in which the compound of the formula (1-8) is present and as mixing partner of one of the abovementioned mixing partners of the numbers 1 to 150, wherein the preferred, particularly preferred and most particularly preferred mixing ratios as above are indicated. A further preferred embodiment of the present invention relates to active ingredient combinations in which the compound of the formula (1-9) is present and as a mixing partner of one of the abovementioned mixing partners of the numbers 1 to 150, wherein the preferred, particularly preferred and very particularly preferred mixing ratios as above are indicated.

A further preferred embodiment of the present invention relates to active ingredient combinations in which the compound of the formula (1-10) is present and as mixing partner of one of the abovementioned mixing partners of the numbers 1 to 150, wherein the preferred, particularly preferred and very particularly preferred mixing ratios as above are indicated.

A further preferred embodiment of the present invention relates to active ingredient combinations in which the compound of the formula (I-1 1) is present and as mixing partner of one of the abovementioned mixing partners of the numbers 1 to 150, the preferred, particularly preferred and very particular preferred mixing ratios are as indicated above.

In the above (particularly) preferred embodiments, only one compound of formula (I) is included in each case.

Further preferred active ingredient combinations are selected from combinations which contain the compound of the formula (1-4) and a further active compound from Table A selected from the compounds with the numbers 1, 2, 3, 5, 6, 12b, 15, 18 , 19, 24, 26, 28, 29, 30, 34, 36, 37, 38, 44, 45, 49, 50, 53, 54, 55, 57, 58, 62, 63, 74, 77, 87, 90 , 92, 93, 94, 95, 96, 97, 98, 99, 100, 101, 102, 103, 104, 105, 106, 108, 109, 111, 112, 113, 114, 148, 149 and 150.

The active compound combinations according to the invention are very suitable for controlling animal pests or undesired microorganisms.

If the abbreviated form of the "common name" of an active ingredient is used in the context of this description, then all common derivatives, such as the esters and salts, and isomers, in particular optical isomers, are included, in particular the commercially available form or forms "Common name" denotes an ester or salt, so are all other common derivatives such as other esters and salts, the free acids and neutral compounds, and isomers, in particular optical isomers, in particular the commercial form or forms. The chemical link names given refer to at least one of the "common name" compounds, often a preferred compound.

Surprisingly, the insecticides and / or acaricidal and / or antimicrobial action, or the fungicidal action and / or the plant-strengthening and / or yield-increasing action of the active compound combinations according to the invention is substantially higher than the sum of the effects of the individual active compounds. There is an unpredictable true synergistic effect and not just an effect supplement.

Further, the compounds of the formula (I) may be mixed with the following herbicides. The same applies to the mixtures according to the invention, in particular to those listed in Table A, which can also be mixed with the following herbicides and applied to plants or plant parts. In many cases, these mixtures with herbicides have synergistic effects.

Fruit / Vegetable Herbicides: Atrazine, Bromacil, Diuron, Glyphosate, Linuron, Metribuzin, Simazine, Trifluralin, Fluazifop, Glufosinate, Halosulfuron Gowan, Paraquat, Propyzamide, Sethoxydim, Butafenacil, Halosulfuron, Indaziflam; Cereal Herbicides: Isoproturon, Bromoxynil, Ioxynil, Phenoxies, Chlorsulfuron, Clodinafop, Diclofop, Diflufenican, Fenoxaprop, Florasulam, Fluroxypyr, Metsulfuron, Triasulfuron, Flucarbazone, Iodosulfuron, Propoxycarbazone, Picolinafen, Mesosulfuron, Beflubutamide, Pinoxaden, Amidosulfuron, Thifensulfuron, Tribenuron, Flupyrsulfuron, Sulfosulfuron, pyrasulfotole, pyroxsulam, flufenacet, tralkoxydim, pyroxasulfone;

Corn herbicides: Atrazine. Alachlor, bromoxynil, acetochlor, dicamba, clopyralid, (5) -dimethenamid, glufosinate, glyphosate, isoxaflutole, (5) -metolachlor, mesotrione, nicosulfuron, primisulfuron, rimsulfuron, sulcotrione, foramsulfuron, toramezone, tembotrione, saflufenacil, thien arbazone, flufenacet , Pyroxasulfone; Rice herbicides: Butachlor. Propanil, Azimsulfuron, Bensulfuron, Cyhalofop, Daimuron, Fentrazamide, Imazosulfuron, Mefenacet, Oxaziclomefone, Pyrazosulfuron, Pyributicarb, Quinclorac, Thiobencarb, Indanofan, Flufenacet, Fentrazamide, Halosulfuron, Oxaziclomefone, Benzobicyclone, Pyriftalid, Penoxsulam, Bispyribac, Oxadiargyl, Ethoxysulfuron, Pretilachlor, Mesotrione, tefuryltrione, oxadiazone, fenoxaprop, pyrimisulfan; Cotton herbicides: Diuron, Fluometuron, MSMA, Oxyfluorfen, Prometry, Trifluralin, Carfentrazone, Clethodim, Fluazifop-butyl, Glyphosate, Norflurazon, Pendimethalin, Pyrithiobac-sodium, Trifloxysulfuron, Tepraloxydim, Glufosinate, Flumioxazin, Thidiazuron;

Soy herbicides: alachlor, bentazone, trifluralin, chlorimuron-ethyl, cloransulam-methyl, fenoxaprop, fomesafen, fluazifop, glyphosate, imazamox, imazaquin, imazethapyr, (<S) -metolachlor, metribuzin, pendimethalin, tepraloxydim, glufosinate;

Sugar beet herbicides: Chloridazon, Desmedipham, Ethofumesate, Phenmedipham, Triallate, Clopyralid, Fluazifop, Lenacil, Metamitron, Quinmerac, Cycloxydim, Triflusulfuron, Tepraloxydim, Quizalofop;

Rape herbicides: Clopyralid, Diclofop, Fluazifop, Glufosinate, Glyphosate, Metazachlor, Trifluralin Ethametsulfuron, Quinmerac, Quizalofop, Clethodim, Tepraloxydim; Particular preference is given to mixtures of compounds of the formula (I) with glyphosate. Further preferred are mixtures of the compound of the formula (I) with glufosinate.

The active compound combinations according to the invention are suitable for good plant tolerance, favorable toxicity to warm-blooded animals and good environmental compatibility for the protection of plants and plant organs, for increasing crop yields, improving the quality of the harvested crop and for controlling animal matter Pests, in particular insects, arachnids, helminths, nematodes and molluscs, found in agriculture, horticulture, livestock, forestry, gardens and recreational facilities, in storage and materials protection and in the hygiene sector. They can preferably be used as crop protection agents. They are effective against normally sensitive and resistant species as well as against all or individual stages of development. The above mentioned pests include:

From the order of the Anoplura (Phthiraptera) e.g. Damalinia spp., Haematopinus spp., Linognathus spp., Pediculus spp., Trichodectes spp.

From the class of arachnids, e.g. Acarus spp., Aceria sheldoni, Aculops spp., Aculus spp., Amblyomma spp., Amphitetranychus viennensis, Argas spp., Boophilus spp., Brevipalpus spp., Bryobia praetiosa, Chorioptes spp., Dermanyssus gallinae, Eotetranychus spp., Epitrimerus pyri , Eutetranychus spp., Eriophyes spp., Halotydeus destructor, Hemitarsonemus spp., Hyalomma spp., Ixodes spp., Latrodectus mactans, Metatetranychus spp., Nuphersa spp., Oligonychus spp., Ornithodoros spp., Panonychus spp., Phyllo- coptruta oleivora, Polyphagotarsonemus latus, Psoroptes spp., Rhipicephalus spp., Rhizoglyphus spp., Sarcoptes spp., Scorpio maurus, Stenotarsonemus spp., Tarsonemus spp., Tetranychus spp., Vasates lycopersici.

From the class of bivalva, e.g. Dreissena spp ..

From the order of Chilopoda e.g. Geophilus spp., Scutigera spp.

From the order of Coleoptera, for example, Acalymma vittatum, Acanthoscelides obtectus, Adoretus spp., Agelastica alni, Agriotes spp., Amphimallon solstitialis, Anobium punctatum, Anoplophora spp., Anthonomus spp., Anthrenus spp., Apion spp., Apogonia spp. , Atomaria spp., Attagenus spp., Bruchidius obtectus, Bruchus spp., Cassida spp., Cerotoma trifurcata, Ceutorrhynchus spp., Chaetocnema spp., Cleonus mendicus, Conoderus spp., Cosmopolites spp., Costelytra zealandica, Ctenicera spp., Curculio spp., Cryptorhynchus lapathi, Cylindrocopturus spp., Dermestes spp., Diabrotica spp., Dichocrocis spp., Diloboderus spp., Epilachna spp., Epitrix spp., Faustinus spp., Gibbium psylloides, Hellula and alis, Heteronychus arator, Heteronyx spp. , Hylamorpha elegans, Hylotrupes bajulus, Hypera postica, Hypo- noemus spp., Lachnosterna consanguinea, Lema spp., Leptinotarsa decemlineata, Leucoptera spp., Lissorhoptrus oryzophilus, Lixus spp., Luperodes spp., Lyctus spp., Megascelis spp. , Melanoms spp., Melig Ethes aeneus, Melolontha spp., Migdolus spp., Monochamus spp., Naupactus xanthographus, Niptus hololeucus, Oryctes rhinoceros, Oryzaephilus surinamensis, Oryzaphagus oryzae, Otiorrhynchus spp., Oxycetonia jucunda, Phaedon cochleariae, Phyllophaga spp., Phyllotreta spp., Popillia japonica, Premnotrypes spp., Psylliodes spp., Ptinus spp., Rhizobius ventralis, Rhizopertha dominica, Sitophilus spp., Sphenophorus spp., Starchus spp., Symphyletes spp., Tanymecus spp., Tenebrio molitor, Tribolium spp., Trogoderma spp., Tychius spp., Xylotrechus spp., Zabrus spp.

From the order of Collembola e.g. Onychiurus armatus.

From the order of diplopoda e.g. Blaniulus guttulatus. From the order of Diptera e.g. Aedes spp., Agromyza spp., Anastrepha spp., Anopheles spp., Asphondylia spp., Bactrocera spp., Bibio hortulanus, Calliphora erythrocephala, Ceratitis capitata, Chironomus spp., Chrysomyia spp., Cochliomyia spp., Contarinia spp., Cordylobia anthropophaga, Culex spp., Cuterebra spp., Dacus oleae, Dasyneura spp., Delia spp., Dermatobia hominis, Drosophila spp., Echinocnemus spp., Fannia spp., Gastrophilus spp., Hydrellia spp., Hylemyia spp., Hyppobosca spp , Hypoderma spp., Liriomyza spp. Lucilla spp., Musca spp., Nezara spp., Oestrus spp., Oscinella frit, Pegomyia spp., Phorbia spp., Prodiplosis spp., Psila rosae, Rhagoletis spp. Stomoxys spp., Tabanus spp., Tannia spp., Tetanops spp., Tipula spp.

From the class Gastropoda, e.g. Arion spp., Biomphalaria spp., Bulinus spp., Deroceras spp., Galba spp., Lymnaea spp., Oncomelania spp., Pomacea spp., Succinea spp. From the class of helminths e.g. Ancylostoma duodenale, Ancylostoma ceylanicum, Acylostoma braziliensis, Ancylostoma spp., Ascaris lubricoides, Ascaris spp., Brugia malayi, Brugia timori, Bunostomum spp., Chabertia spp., Clonorchis spp., Cooperia spp., Dicrocoelium spp, Dictyocaulus filaria, Diphyllobothrium latum , Dracunculus medinensis, Echinococcus granulosus, Echinococcus multilocularis, Enterobius vermicularis, Faciola spp., Haemonchus spp., Heterakis spp., Hymenolepis nana, Hyostrongulus spp., Loa Loa, Nematodirus spp., Oesophagostomum spp., Opisthorchis spp., Onchocerca volvulus, Ostertagia spp., Paragonimus spp., Schistosome spp, Strongyloides fuelleborni, Strongyloides stercoralis, Stronyloides spp., Taenia saginata, Taenia solium, Trichinella spiralis, Trichinella nativa, Trichinella britovi, Trichinella nelsoni, Trichinella pseudopsiralis, Trichostrongulus spp., Trichuris trichuria, Wuchereria bancrofti. Furthermore, protozoa, such as Eimeria, can be combated.

From the order of the Heteroptera eg Anasa tristis, Antestiopsis spp., Blissus spp., Calocoris spp., Campylomma livida, Cavelerius spp., Cimex spp., Collaria spp., Creontiades dilutus, Dasynus piperis, Dichelops furcatus, Diconocoris hewetti, Dysdercus spp , Eusystus spp., Eurygaster spp., Heliopeltis spp., Horcias nobilellus, Leptocorisa spp., Leptoglossus phyllopus, Lygus spp., Macropes excavatus, Miridae, Monaionion atratum, Nezara spp., Oebalus spp., Pentomidae, Piesma quadrata, Piezodorus spp, psallus spp., Pseudacysta persea, Rhodnius spp., Sahlbergella singularis, Scaptocoris castanea, Scotinophora spp., Stephanitis nashi, Tibraca spp., Triatoma spp.

From the order of Homoptera e.g. Acyrthosipon spp., Acrogonia spp., Aeneolamia spp., Agonoscena spp., Aleurodes spp., Aleurolobus barodensis, Aleurothrixus spp., Amrasca spp., Anuraphis cardui, Aemonidella spp., Aphanostigma piri, Aphis spp., Arboridia apicalis, Aspidiella spp., Aspidiotus spp., Atanus spp., Aulacorthum solani, Bemisia spp., Brachycaudus helichrysii, Brachycolus spp., Brevicoryne brassicae, Calligypona marginata, Carneocephala fulgida, Ceratovacuna lanigera, Cercopidae, Ceroplastes spp., Chaetosiphon fragaefolii, Chionetis tegalensis, Chlorita onukii, Chromaphis juglandicola, Chrysomphalus ficus, Cicadulina mbila, Coccomytilus halli, Coccus spp., Cryptomyzus ribis, Dalbulus spp., Dialeurodes spp., Diaphorina spp., Diaspis spp., Drosicha spp., Dysaphis spp., Dysmicoccus spp. Empoasca spp., Eriosome spp., Erythroneura spp., Euscelis bilobatus, Ferrisia spp., Geococcus coffeae, Hieroglyphus spp., Homalodisca coagulata, Hyalopterus arundinis, Icerya spp., Idiocerus spp., Idioscopus spp., Laodelphax s triatellus, Lecanium spp., Lepidosaphes spp., Lipaphis erysimi, Macrosiphum spp., Mahanarva spp., Melanaphis sacchari, Metcalfiella spp., Metopolophium dirhodum, Monellia costalis, Monelliopsis pecanis, Myzus spp., Nasonovia ribisnigri, Nephotettix spp., Nilaparvata lugens , Oncometopia spp., Orthezia praeonga, Parabemisia myricae, Paratrioza spp., Parlatoria spp., Pemphigus spp., Peregrinus maidis, Phenacoccus spp., Phloeomyzus passerinii, Phorodon humuli, Phylloxera spp., Pinnaspis aspidistrae, Planococcus spp., Protopulvinaria pyriformis, Pseudaulacaspis pentagona, Pseudococcus spp., Psylla spp., Pteromalus spp., Pyrilla spp., Quadraspidiotus spp., Quesada gigas, Rastrococcus spp., Rhopalosiphum spp., Saissetia spp., Scaphoides titanus, Schizaphis graminum, Selenaspidus articulatus, Sogata Spp., Sogatella furcifera, Sogatodes spp., Stictocephala festina, Tenalaphara malayensis, Tinocallis caryaefoliae, Tomaspis spp., Toxoptera spp., Trialeurodes spp., Trioza spp., Typhlocyba spp., Unaspis spp., Viteus vitifolii, Zygina spp.

From the order of Hymenoptera e.g. Athalia spp., Diprion spp., Hoplocampa spp., Lasius spp., Monorium pharaonis, Vespa spp.

From the order of isopods e.g. Armadillidium vulgare, Oniscus asellus, Porcellio scaber.

From the order of Isoptera e.g. Acromyrmex spp., Atta spp., Cornitermes cumulans, Microtermes obesi, Odontotermes spp., Reticulitermes spp,

From the order of Lepidoptera, for example, Acronicta major, Adoxophyes spp., Aedia leucomelas, Agrotis spp., Alabama spp., Amyelois transitella, Anarsia spp., Anticarsia spp., Argyroploce spp., Barathra brassicae, Borbo cinnara, Bucculatrix thurberiella, Bupalus piniarius , Busseola spp., Cacoecia spp., Caloptilia theivora, Capua reticulana, Carpocapsa pomonella, Carposina niponensis, Cheimatobia brumata, Chilo spp., Choristoneura spp., Clysia ambiguella, Cnaphalocerus spp., Cnephasia spp., Conopomorpha spp., Conotrachelus spp., Copitarsia spp., Cydia spp., Dalaca noctuides, Diaphania spp., Diatraea saccharalis, Earias spp., Ecdytolopha aurantium, Elasmopalpus lignosellus, Eidana saccharina, Ephestia kuehniella, Epinotia spp., Epiphyas postvittana, Etiella spp., Eulia spp., Eupoecilia ambiguella, Euproctis spp., Euxoa spp., Feltia Spp., Galleria mellonella, Gracillaria spp., Grapholitha spp., Hedylepta spp., Helicoverpa spp., Heliothis spp., Hofmannophila pseudospretella, Homoeosoma spp., Homona spp., Hyponomeuta padella, Kakivoria flavofasciata, Laphygma spp., Laspeyresia molesta, Leucinodes orbonalis, Leucoptera spp., Lithocolletis spp., Lithophane antennata, Lobesia spp., Loxagrotis albicosta, Lymantria spp., Lyonetia spp., Malacosoma neustria, Maruca testulalis, Mamestra brassicae, Mocis spp., Mythimn a separata, Nymphula spp., Oiketicus spp., Oria spp., Orthaga spp., Ostrinia spp., Oulema oryzae, Panolis flammea, Parnara spp., Pectinophora spp., Perileucoptera spp., Phthorimaea spp., Phyllocnistis citrella, Phyllonorycter spp , Pieris spp., Platynota stultana, Plusia spp., Plutella xylostella, Prays spp., Prodenia spp., Protoparce spp., Pseudodia spp., Pseudoplusia includens, Pyrausta nubilalis, Rachiplusia nu, Schoenobius spp., Scirpophaga spp. , Scotia segetum, Sesamia spp., Sparganothis spp., Spodoptera spp., Stathmopoda spp., Stomopteryx subsecivella, Synanthedon spp., Tecia solanivora, Thermesia gemmatalis, Tinea pellionella, Tineola bisselliella, Tortrix spp., Trichoplusia spp., Tuta absoluta, Virachola spp ..

From the order of Orthoptera e.g. Acheta domesticus, Blatta orientalis, Blattella germanica, Dichroplus spp., Gryllotalpa spp., Leucophaea maderae, Locusta spp., Melanoplus spp., Periplaneta americana, Schistocerca gregaria.

From the order of siphonaptera e.g. Ceratophyllus spp., Xenopsylla cheopis.

From the order of Symphyla e.g. Scutigerella spp ..

From the order of Thysanoptera e.g. Anaphothrips obscurus, Baliothrips biformis, Drepanothris reuteri, Enneothrips flavens, Frankliniella spp., Heliothrips spp., Hercinothrips femoralis, Rhipiphorothrips cruentatus, Scirtothrips spp., Taeniothrips cardamoni, Thrips spp.

From the order of Thysanura e.g. Lepisma saccharina.

The plant parasitic nematodes include, for example, Aphelenchoides spp., Bursaphelenchus spp., Ditylenchus spp., Globodera spp., Heterodera spp., Longidorus spp., Meloidogyne spp., Pratylenchus spp., Radopholus similis, Trichodorus spp., Tylenchulus semipenetrans, Xiphinema spp The present invention further relates to formulations and application forms prepared therefrom Plant protection products and / or pesticides such. B. drench, drip and spray, comprising at least one of the active compounds according to the invention. If appropriate, the use forms contain other crop protection agents and / or pesticides and / or the effect of improving adjuvants such as penetration enhancers, eg. As vegetative oils such as rapeseed oil, sunflower oil, mineral oils such as paraffin oils, alkyl esters of vegetable fatty acids such as rapeseed oil or soybean oil or alkanol alkoxylates and / or spreading agents such as alkyl siloxanes and / or salts z. As organic or inorganic ammonium or phosphonium salts such as ammonium sulfate or diammonium hydrogen phosphate and / or retention-promoting agents such. As dioctylsulfosuccinate or hydroxypropyl guar polymers and / or humectants such. As glycerol and / or fertilizers such as ammonium, potassium or phosphorus-containing fertilizer.

Typical formulations are, for example, water-soluble liquids (SL), emulsion concentrates (EC), emulsions in water (EW), suspension concentrates (SC, SE, FS, OD), water-dispersible granules (WG), granules (GR) and capsule concentrates (CS). ; These and other possible formulation types are described, for example, by Crop Life International and in Pesticide Specifications, Manual on Development and Use of FAO and WHO Specifications for Pesticides, FAO Plant Production and Protection Papers - 173, prepared by the FAO / WHO Joint Meeting on Pesticide Specifications, 2004, ISBN: 9251048576. If appropriate, the formulations contain, in addition to one or more active compounds according to the invention, further agrochemical active substances. They are preferably formulations or use forms which contain auxiliaries, such as extenders, solvents, spontaneity promoters, carriers, emulsifiers, dispersants, antifreeze agents, biocides, thickeners and / or further auxiliaries, for example adjuvants. An adjuvant in this context is a component that enhances the biological effect of the formulation without the component itself having a biological effect. Examples of adjuvants are agents that promote retention, spreading behavior, adherence to the leaf surface, or penetration.

These formulations are prepared in a known manner, e.g. by mixing the active ingredients with excipients such as extenders, solvents and / or solid carriers and / or other excipients such as surfactants. The preparation of the formulations is carried out either in suitable systems or before or during use.

As adjuvants, it is possible to use those substances which are suitable for the formulation of the active ingredient or for the forms of use prepared from these formulations (such as, for example, ready-to-use formulations) Plant protection products such as spray liquors or seed dressing) to impart special properties, such as certain physical, technical and / or biological properties.

As extender, e.g. Water, polar and non-polar organic chemical liquids e.g. from the classes of aromatic and non-aromatic hydrocarbons (such as paraffins, alkylbenzenes, alkylnaphthalenes, chlorobenzenes), alcohols and polyols (which may also be substituted, etherified and / or esterified), ketones (such as acetone, cyclohexanone), Esters (including fats and oils) and (poly) ethers, simple and substituted amines, amides, lactams (such as N-alkylpyrrolidones) and lactones, sulfones and sulfoxides (such as dimethylsulfoxide).

In the case of using water as an extender, e.g. also organic solvents can be used as auxiliary solvents. Suitable liquid solvents are essentially: aromatics, such as xylene, toluene or alkylnaphthalenes, chlorinated aromatics or chlorinated aliphatic hydrocarbons, such as chlorobenzenes, chloroethylenes or methylene chloride, aliphatic hydrocarbons, such as cyclohexane or paraffins, e.g. Petroleum fractions, mineral and vegetable oils, alcohols such as butanol or glycol and their ethers and esters, ketones such as acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strongly polar solvents such as dimethylformamide and dimethyl sulfoxide, and water.

In principle, all suitable solvents can be used. Suitable solvents are, for example, aromatic hydrocarbons, e.g. Xylene, toluene or alkylnaphthalenes, chlorinated aromatic or aliphatic hydrocarbons, e.g. Chlorobenzene, chloroethylene, or methylene chloride, aliphatic hydrocarbons, e.g. Cyclohexane, paraffins, petroleum fractions, mineral and vegetable oils, alcohols, e.g. Methanol, ethanol, iso-propanol, butanol or glycol and their ethers and esters, ketones such as e.g. Acetone, methyl ethyl ketone, methyl isobutyl ketone or cyclohexanone, strong polar solvents, such as dimethyl sulfoxide, and water.

In principle, all suitable carriers can be used. Suitable carriers are in particular: for example, ammonium salts and ground natural minerals, such as kaolins, clays, talc, chalk, quartz, attapulgite, montmorillonite or diatomaceous earth and ground synthetic minerals, such as finely divided silica, alumina and natural or synthetic silicates, resins, waxes and / or solid Fertilizer. Mixtures of such carriers can also be used. Suitable carriers for granules are: eg broken and fractionated natural rocks such as calcite, marble, pumice, sepiolite, dolomite and synthetic granules of inorganic and organic flours and granules of organic material such as sawdust, paper, coconut shells, corn cobs and tobacco stems. Also, liquefied gaseous diluents or solvents can be used. Particularly suitable are those extenders or carriers which are gaseous at normal temperature and under atmospheric pressure, for example aerosol propellants, such as halogenated hydrocarbons, as well as butane, propane, nitrogen and carbon dioxide. Examples of emulsifying and / or foaming agents, dispersants or wetting agents having ionic or nonionic properties or mixtures of these surfactants are salts of polyacrylic acid, salts of lignosulphonic acid, salts of phenolsulphonic acid or naphthalenesulphonic acid, polycondensates of ethylene oxide with fatty alcohols or with Fatty acids or with fatty amines, with substituted phenols (preferably alkylphenols or arylphenols), salts of sulphosuccinic acid esters, taurine derivatives (preferably alkyltaurates), phosphoric acid esters of polyethoxylated alcohols or phenols, fatty acid esters of polyols, and derivatives of the compounds containing sulphates, sulphonates and phosphates, for example alkylarylpolyglycol ethers, Alkyl sulfonates, alkyl sulfates, arylsulfonates, protein hydrolysates, lignin-sulphite liquors and methylcellulose. The presence of a surfactant is advantageous when one of the active ingredients and / or one of the inert carriers is not soluble in water and when applied in water.

As further adjuvants, in the formulations and the applications derived therefrom, dyes such as inorganic pigments, e.g. Iron oxide, titanium oxide, ferrocyan blue and organic dyes such as alizarin, azo and metal phthalocyanine dyes, and nutrient and trace nutrients such as salts of iron, manganese, boron, copper, cobalt, molybdenum and zinc. Stabilizers such as cold stabilizers, preservatives, antioxidants, light stabilizers or other chemical and / or physical stability-improving agents may also be present. It may also contain foam-forming agents or defoamers.

Further, the formulations and applications derived therefrom may also contain, as additional auxiliaries, adhesives such as carboxymethyl cellulose, natural and synthetic powdery, granular or latex polymers such as gum arabic, polyvinyl alcohol, polyvinyl acetate, and natural phospholipids such as cephalins and lecithins, and synthetic phospholipids. Other auxiliaries may be mineral and vegetable oils.

Optionally, further auxiliaries may be present in the formulations and in the use forms derived therefrom. Such additives are, for example, fragrances, protective colloids, binders, adhesives, thickeners, thixotropic substances, penetration promoters, retention promoters, stabilizers, sequestrants, complexing agents, humectants, spreading agents. In general, the Active ingredients can be combined with any solid or liquid additive commonly used for formulation purposes.

As retention promoters are all those substances which reduce the dynamic surface tension such as dioctylsulfosuccinate or increase the visco-elasticity such as hydroxypropyl guar polymers.

Suitable penetration promoters in the present context are all those substances which are usually used to improve the penetration of agrochemical active substances into plants. Penetration promoters are in this context defined by the fact that they can penetrate from the (usually aqueous) application broth and / or from the spray coating into the cuticle of the plant and thereby increase the material mobility (mobility) of the active ingredients in the cuticle. The method described in the literature (Baur et al., 1997, Pesticide Science 51, 131-152) can be used to determine this property. Examples include alcohol alkoxylates such as coconut oil ethoxylate (10) or isotridecyl ethoxylate (12), fatty acid esters such as rapeseed oil or soybean oil, fatty amine alkoxylates such as tallowamine ethoxylate (15) or ammonium and / or phosphonium salts such as ammonium sulfate or diammonium hydrogen phosphate.

According to the invention, all plants and parts of plants can be treated. In this context, plants are understood as meaning all plants and plant populations, such as desired and undesired wild plants or crop plants (including naturally occurring crop plants). Crop plants can be plants which can be obtained by conventional breeding and optimization methods or by biotechnological and genetic engineering methods or combinations of these methods, including the transgenic plants and including the plant varieties which can or can not be protected by plant breeders' rights. The plants which can be treated with the active compound combinations according to the invention include, for. The following plant species: turf, vines, cereals, for example wheat, barley, rye, oats, rice, maize and millet; Beets, for example sugar beets and fodder beets; Fruits, such as pome fruit, stone fruit and soft fruit, such as apples, pears, plums, peaches, almonds, cherries and berries, eg. Strawberries, raspberries, blackberries; Legumes, such as beans, lentils, peas and soybeans; Oil crops such as rapeseed, mustard, poppy, olive, sunflower, coconut, castor oil, cocoa beans and peanuts; Cucurbits, for example squash, cucumbers and melons; Fiber plants, for example cotton, flax, hemp and jute; Citrus fruits, such as oranges, lemons, grapefruit and mandarins; Vegetables, such as spinach, (head) salad, asparagus, cabbages, carrots, onions, tomatoes, potatoes and Paprika; Laurel family, such as avocado, Cinnamomum, camphor, or as plants such as tobacco, nuts, coffee, eggplant, sugar cane, tea, pepper, vines, hops, bananas, natural rubber plants and ornamental plants, such as flowers, shrubs, deciduous trees and conifers such as conifers. Plant parts are to be understood as meaning all aboveground and underground parts and organs of the plants, such as shoot, leaf, flower and root, by way of example, leaves, needles, stems, stems, flowers, fruiting bodies, fruits and seeds and Roots, tubers and rhizomes are listed. The plant parts also include crops as well as vegetative and generative propagation material, for example cuttings, tubers, rhiomes, offshoots and seeds. The treatment according to the invention of the plants and plant parts with the active ingredient combinations takes place directly or by acting on their environment, habitat or storage space according to the usual treatment methods, eg by dipping, spraying, evaporating, casting, atomizing, spreading, brushing and in propagation material, in particular in seeds, furthermore by single or multi-layer wrapping. As already mentioned above, according to the invention all plants and their parts can be treated. In a preferred embodiment, wild-type or plant species obtained by conventional biological breeding methods, such as crossing or protoplast fusion, and plant cultivars and their parts are treated. In a further preferred embodiment, transgenic plants and plant cultivars which have been obtained by genetic engineering methods, if appropriate in combination with conventional methods (Genetically Modified Organisms), and parts thereof are treated. The terms "parts" or "parts of plants" or "plant parts" have been explained above.

It is particularly preferred according to the invention to treat plants of the respective commercially available or in use plant cultivars.

Depending on the plant species or plant cultivars, their location and growth conditions (soils, climate, vegetation period, diet), the treatment according to the invention may also give rise to superadditive ("synergistic") effects. Thus, for example, reduced application rates and / or extensions of the spectrum of action and / or an increase in the effect of the substances and agents usable in the invention, better plant growth, increased tolerance to high or low temperatures, increased tolerance to drought or to water or soil salt content, increased flowering power facilitated harvest, acceleration of ripeness, higher crop yields, higher quality and / or higher nutritional value of the harvested products, higher shelf life and / or machinability of the harvested products, which exceed the actual expected effects. The preferred plants or plant varieties to be treated according to the invention to be treated include all plants which, as a result of the genetic engineering modification, obtained genetic material which gives these plants particularly advantageous valuable properties ("traits"). Examples of such properties are better plant growth, increased tolerance to high or low temperatures, increased tolerance to dryness or to bottoms salt, increased flowering, easier harvesting, acceleration of ripeness, higher crop yields, higher quality and / or higher nutritional value of the harvested products , higher shelf life and / or workability of the harvested products. Further and particularly emphasized examples of such properties are an increased defense of the plants against animal and microbial pests, as against insects, mites, phytopathogenic fungi, bacteria and / or viruses as well as an increased tolerance of the plants against certain herbicidal active substances. Examples of transgenic plants include the important crops such as cereals (wheat, rice), corn, soy, potato, cotton, rapeseed and fruit plants (with the fruits apples, pears, citrus fruits and grapes), with corn, soy, potato, cotton and rapeseed should be highlighted. Traits which are particularly emphasized are the increased defense of the plants against insects by toxins which are formed in the plants, in particular those which are produced by the genetic material from Bacillus thuringiensis (for example by the genes CrylA (a), CrylA (b), CrylA (c), CryllA, CrylllA, CryIIIB2, Cry9c Cry2Ab, Cry3Bb and CrylF and combinations thereof) are produced in the plants (hereinafter "Bt plants"). Traits which are furthermore particularly emphasized are the increased tolerance of the plants to certain herbicidally active compounds, for example imidazolinones, sulfonylureas, glyphosate or phosphinotricin (eg "PAT" gene). The genes which confer the desired properties ("traits") can also occur in combinations with one another in the transgenic plants. Examples of "Bt plants" are maize varieties, cotton varieties, soya bean varieties and potato varieties which are sold under the trade names YIELD GARD ^® (for example maize, cotton, soya beans), KnockOut ^® (for example maize), StarLink ^® (for example maize), Bollgard ^® ( cotton), NuCOTN ^® (cotton) and NewLeaf ^® (potato). Examples of herbicide-tolerant plants are maize varieties, cotton varieties and soybean varieties which are resistant under the trade names Roundup Ready ^® (tolerance to glyphosate, for example maize, cotton, soya bean), Liberty Link ^® (tolerance to phosphinotricin, for example oilseed rape), IMI ^® (tolerance Imidazolinone) and STS ^® (tolerance to sulfonylureas such as corn) are sold. Herbicide-resistant (conventionally grown on herbicide tolerance) plants are also the varieties marketed under the name Clearfield ^® (eg corn) mentioned. Of course, these statements also apply to future or future marketed plant varieties with these or future developed genetic traits. The listed plants can be treated particularly advantageously according to the invention with the active substance mixtures according to the invention. The preferred ranges given above for the active substance combinations also apply to the treatment of these plants. Particularly emphasized is the plant treatment with the active ingredient combinations specifically mentioned in the present text. The active compound combinations according to the invention have an increased microbicidal action (in comparison to the microbially active compounds within the groups F1 to F14) and can be used for controlling unwanted microorganisms, such as fungi and bacteria, in crop protection and in the protection of materials.

Fungicides can be used for the control of Plasmodiophoromycetes, Oomycetes, Chytriomycetes, Zygomycetes, Ascomycetes, Basidiomycetes and Deuteromycetes.

Bactericides can be used in crop protection for controlling Pseudomonadaceae, Rhizobiaceae, Enterobacteriaceae, Corynebacteriaceae and Streptomycetaceae.

By way of example but not limitation, some pathogens of fungal and bacterial diseases, which fall under the above-enumerated generic terms, are named:

Diseases caused by powdery mildews such as e.g.

Blumeria species such as Blumeria graminis;

Podosphaera species, such as Podosphaera leucotricha;

Sphaerotheca species, such as Sphaerotheca fuliginea;

Uncinula species, such as Uncinula necator;

Diseases caused by causative agents of rust diseases, such as

Gymnosporangium species, such as Gymnosporangium sabinae

Hemileia species, such as Hemileia vastatrix;

Phakopsora species such as Phakopsora pachyrhizi and Phakopsora meibomiae;

Puccinia species, such as Puccinia recondita;

Uromyces species, such as Uromyces appendiculatus;

Diseases caused by pathogens of the group of Oomycetes, e.g.

Bremia species, such as Bremia lactucae;

Peronospora species such as Peronospora pisi or P. brassicae;

Phytophthora species, such as Phytophthora infestans;

Plasmopara species, such as Plasmopara viticola;

Pseudoperonospora species, such as Pseudoperonospora humuli or

Pseudoperonospora cubensis; Pythium species such as Pythium ultimum;

Leaf spot diseases and leaf wilt caused by e.g.

Alternaria species, such as Alternaria solani;

Cercospora species, such as Cercospora beticola;

Cladosporium species, such as Cladosporium cucumerinum;

Cochliobolus species, such as Cochliobolus sativus

(Conidia form: Drechslera, Syn: Helminthosporium);

Colletotrichum species, such as Colletotrichum lindemuthanium;

Cycloconium species such as cycloconium oleaginum;

Diaporthe species, such as Diaporthe citri;

Elsinoe species, such as Elsinoe fawcettii;

Gloeosporium species, such as, for example, Gloeosporium laeticolor;

Glomerella species, such as Glomerella cingulata;

Guignardia species, such as Guignardia bidwelli;

Leptosphaeria species, such as Leptosphaeria maculans;

Magnaporthe species, such as Magnaporthe grisea;

Mycosphaerella species, such as Mycosphaerella graminicola and Mycosphaerella fijiensis;

Phaeosphaeria species, such as Phaeosphaeria nodorum;

Pyrenophora species, such as, for example, Pyrenophora teres;

Ramularia species, such as Ramularia collo-cygni;

Rhynchosporium species, such as Rhynchosporium secalis;

Septoria species, such as Septoria apii;

Typhula species, such as Typhula incarnata;

Venturia species, such as Venturia inaequalis;

Root and stem diseases caused by e.g.

Corticium species, such as Corticium graminearum;

Fusarium species such as Fusarium oxysporum;

Gaeumannomyces species such as Gaeumannomyces graminis;

Rhizoctonia species, such as Rhizoctonia solani;

Tapesia species, such as Tapesia acuformis;

Thielaviopsis species, such as Thielaviopsis basicola;

Ear and panicle diseases (including corncob) caused by e.g.

Alternaria species, such as Alternaria spp .;

Aspergillus species, such as Aspergillus flavus; Cladosporium species, such as Cladosporium cladosporioides;

Claviceps species, such as Claviceps purpurea;

Fusarium species such as Fusarium culmorum;

Gibberella species, such as Gibberella zeae;

Monographella species, such as Monographella nivalis;

Diseases caused by fire fungi, e.g.

Sphacelotheca species, such as Sphacelotheca reiliana;

Tilletia species such as Tilletia caries;

Urocystis species, such as Urocystis occulta;

Ustilago species such as Ustilago nuda;

Fruit rot caused by e.g.

Aspergillus species, such as Aspergillus flavus;

Botrytis species, such as Botrytis cinerea;

Penicillium species such as Penicillium expansum and Penicillium puφurogenum;

Sclerotinia species, such as Sclerotinia sclerotiorum;

Verticilium species such as Verticilium alboatrum;

Seed and soil rots and wilts, as well as seedling diseases caused by e.g.

Fusarium species such as Fusarium culmorum;

Phytophthora species, such as Phytophthora cactorum;

Pythium species such as Pythium ultimum;

Rhizoctonia species, such as Rhizoctonia solani;

Sclerotium species, such as Sclerotium rolfsii;

Cancers, galls and witches brooms caused by e.g.

Nectria species, such as Nectria galligena;

Wilt diseases caused by e.g.

Monilinia species, such as Monilinia laxa;

Deformations of leaves, flowers and fruits caused by e.g.

Taphrina species, such as Taphrina deformans;

Degenerative diseases of woody plants caused by e.g.

Esca species such as Phaeomoniella chlamydospora and Phaeoacremonium aleophilum and Fomitiporia mediterranea;

Flower and seed diseases caused by e.g.

Botrytis species, such as Botrytis cinerea;

Diseases of plant tubers, caused by eg Rhizoctonia species, such as Rhizoctonia solani;

Helminthosporium species, such as Helminthosporium solani;

Diseases caused by bacterial agents such as e.g.

Xanthomonas species, such as Xanthomonas campestris pv. Oryzae;

Pseudomonas species, such as Pseudomonas syringae pv. Lachrymans;

Erwinia species, such as Erwinia amylovora;

Preferably, the following diseases of soybean beans can be controlled:

Fungal diseases on leaves, stems, pods and seeds caused by e.g.

Alternaria leaf spot (Alternaria spec. Atrans tenuissima), Anthracnose (Colletotrichum gloeosporoides dematium var. Truncatum), Brown spot (Septoria glycines), Cercospora leaf spot and blight (Cercospora kikuchii), Choanephora leaf blight (Choanephora infundibulifera trispora (Syn.)) , Dactuliophora leaf spot (Dactuliophora glycines), Downy Mildew (Peronospora manshurica), Drechslera blight (Drechslera glycini), Frogeye leaf spot (Cercospora sojina), Leptosphaerulina leaf spot (Leptosphaerulina trifolii), Phyllostica leaf spot (Phyllosticta sojaecola), Pod and Stem Blight (Phomopsis sojae), Powdery Mildew (Microsphaera diffusa), Pyrenochaeta Leaf Spot (Pyrenochaeta glycines), Rhizoctonia Aerial, Foliage, and Web Blight (Rhizoctonia solani), Rust (Phakopsora pachyrhizi), Scab (Sphaceloma glycines), Stemphylium Leaf Blight ( Stemphylium botryosum), Target Spot (Corynespora cassiicola)

Fungal diseases on roots and stem base caused by e.g. Black Root Red (Calonectria crotalariae), Charcoal Red (Macrophomina phaseolina), Fusarium Blight or Wilt, Root Red, and Pod and Collar Red (Fusarium oxysporum, Fusarium orthoceras, Fusarium semitectum, Fusarium equiseti), Mycoleptodiscus Root Red (Mycoleptodiscus terrestris), Neocosmospora (Neocosmopspora vasinfecta), Pod and Stem Blight (Diaporthe phaseolorum), Stem Canker (Diaporthe phaseolorum var. Caulivora), Phytophthora red (Phytophthora megasperma), Brown Stem Red (Phialophora gregata), Pythium Red (Pythium aphanidermatum, Pythium irregular, Pythium Debaryanum, Pythium myriotylum, Pythium ultimum), Rhizoctonia Root Red, Stem Decay, and Damping Off (Rhizoctonia solani), Sclerotinia Stem Decay (Sclerotinia sclerotiorum), Sclerotinia Southern Blight (Sclerotinia rolfsii), Thielaviopsis Root Red (Thielaviopsis basicola).

The good effect of the active compound combinations according to the invention is evident from the following examples. While the individual active ingredients have weaknesses in effect, the combinations show an effect that goes beyond a simple action summation. A synergistic effect is always present when the effect of the active ingredient combinations is greater than the sum of the effects of the individually applied active ingredients.

applications

The expected effect for a given combination of two drugs can be found in S.R. Colby, Weeds L5 (1967), 20-22 are calculated as follows:

If

X is the degree of killing, expressed in% of the untreated control, when using the active ingredient A at a rate of m g / ha or in a concentration of m ppm,

Y means the degree of killing, expressed in% of the untreated control, when using the active ingredient B in an application rate of n g / ha or in a concentration of n ppm, and

E is the killing degree, expressed in% of the untreated control, when using the active compounds A and B in application rates of m and n g / ha or in a concentration of m and n ppm, then is

XY

E = X + Y- _{1 00}

If the actual kill rate is greater than calculated, the combination is over-additive in its kill, i. there is a synergistic effect. In this case, the actually observed kill rate must be greater than the expected kill rate (E) value calculated from the above formula.

Example A Myzus persicae test

Solvent: 78 parts by weight of acetone

1.5 parts by weight of dimethylformamide

Emulsifier: 0.5 part by weight of alkylaryl polyglycol ether

To prepare a suitable preparation of active compound, 1 part by weight of active compound is mixed with the indicated amounts of solvent and emulsifier, and the concentrate is diluted with emulsifier-containing water to the desired concentration. Cabbage leaves {Brassica oleracea) which are heavily infested with the green peach aphid (Myzus persicae) are treated by spraying with the preparation of active compound in the desired concentration.

After the desired time the kill is determined in%. 100% means that all aphids have been killed; 0% means that no aphids have been killed. The determined kill values are calculated according to the Colby formula.

In this test, z. For example, the following drug combinations have a synergistically enhanced efficacy compared to the individually applied drugs:

Table A-1: Myzus persicae test

Drug concentration killing

in g / ha in% to l ^d

Compound of the formula 1-4 100 80

20 80

4 70

0.8 0

1- [2-fluoro-4-methyl-5 - [(2,2,2-trifluoroethyl) sulfinyl] phenyl] -3- 4 0

(trifluoromethyl) -1H-1, 2,4-triazole-5-amine

Compound of the formula 1-4 + 1- [2- * * * *

Fluoro-4-methyl-5 - [(2,2,2- 0,8 + 4 80 0

trifluoroethyl) sulfinyl] phenyl] -3- (trifluoromethyl) -1H-1,2,4-triazole-5-amine (1: 5)

Bacillus firmus 1-1582

250 0

Compound of formula 1-4 + matched. * *

Bacillus firmus 1-1582 (1: 12.5) 20 + 250 100 80

azadirachtin

100 0

Compound of formula 1-4 + matched. * *

Azadirachtin (1: 125) 0.8 + 100 70 0

Fluensulfone

1000 0

Compound of formula 1-4 + matched. * *

Fluene sulfone (1: 1250) 0.8 + 1000 70 0

pyrethrum

100 80

Compound of formula 1-4 + matched. * *

Pyrethrum (1: 125) 0.8 + 100 100 80 Active substance concentration killing in s / ha in% after l ^d

Mixture of 1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl-6 - 0.8 0

[(Methylamino) carbonyl] phenyl] -3

[[5- (trifluoromethyl) -2H-tetrazol-2-ylmethyl] -1H-pyrazole-5-carboxamide and 1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl-6 [ (methylamino) carbonyl] phenyl] - 3 - [[5- (trifluoromethyl) -1H-tetrazol-1-ylmethyl] -1H-pyrazole-5-carboxamide (ca 91: 9)

Compound of formula 1-4 + found. * * Mixture of 1- (3-chloro-2-4 + 0.8 90 70 pyridinyl) -N- [4-cyano-2-methyl-6 - [(methylamino ) carbonyl] phenyl] -3

[[5- (trifluoromethyl) -2H-tetrazol-2-ylmethyl] -1H-pyrazole-5-carboxamide and 1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl-6 [ (methylamino) carbonyl] phenyl] - 3 - [[5- (trifluoromethyl) -1H-tetrazol-1-ylmethyl] -1H-pyrazole-5-carboxamide (5: 1)

4 - {[(6-αύοφγτ -3-γ1) πιβΛγ1] (2,2-difluoroethyl) amino} furan-2 (5H) -one 20 0

Compound of the formula 1-4 + 4 - {[(6-dibenzo. * * Chloro-3-yl-3-yl) -methyl] (2,2- 0,8 + 20 70 0 difluoroethyl) amino} furan-2 ( 5H) -one

(1:25)

flonicamid

0.8 0

Compound of formula 1-4 + found. * * Flonicamid (1: 1) 0.8 + 0.8 80 0

imidacloprid

0.16 0

Compound of formula 1-4 + found. * * Imidacloprid (5: 1) 0.8 + 0.16 70 0

thiacloprid

0.16 0

Compound of formula 1-4 + found. * * Thiacloprid (5: 1) 0.8 + 0.16 70 0 Active substance concentration killing in s / ha in% after l ^d

thiamethoxam

0.16 0

Compound of formula 1-4 + found. * * Thiamethoxam (5: 1) 0.8 + 0.16 80 0

pyridalyl

0.16 80

Compound of formula 1-4 + found. * * Pyralidyl (5: 1) 0.8 + 0.16 80 0

chlorpyrifos

0.8 0

Compound of formula 1-4 + found. * * Chlorpyrifos (1: 1) 0.8 + 0.8 80 0

thiodicarb

0.8 0

Compound of formula 1-4 + found. * * Thiodicarb (1: 1) 0.8 + 0.8 80 0

Beta-cyfluthrin

0.032 0

Compound of Formula 1-4 + Beta-Fatty Acid * * Cyfluthrin (25: 1) 0.8 + 0.032 70 0

deltamethrin

0.032 0

Compound of formula 1-4 + found. * * Deltamethrin (25: 1) 0.8 + 0.032 80 0

Gamma-cyhalothrin

0.032 0

Compound of formula 1-4 + found. * * Gamma-cyhalothrin (25: 1) 0.8 + 0.032 80 0

triazophos

20 0

Compound of formula 1-4 + found. * * Triazophos (1: 1) 20 + 20 100 80

ethiprole

0.16 0

Compound of formula 1-4 + found. * * Ethiprole (5: 1) 0.8 + 0.16 80 0

lufenuron

100 0 Drug concentration killing

in s / ha in% to l ^d

Compound of formula 1-4 + matched. * *

Lufenuron (1: 1) 100 + 100 100 80

Alpha-cypermethrin

0.032 0

Compound of Formula 1-4 + Alpha Fever. * *

Cypermethrin (25: 1) 0.8 + 0.032 80 0

tebufenozide

0.8 0

Compound of formula 1-4 + matched. * *

Tebufenozide (1: 1) 0.8 + 0.8 70 0

tefluthrin

0.16 0

Compound of formula 1-4 + matched. * *

Tefluthrin (5: 1) 0.8 + 0.16 80 0

fenamiphos

0.8 0

Compound of formula 1-4 + matched. * *

Fenamiphos (1: 1) 0.8 + 0.8 70 0

carbaryl

100 0

Compound of formula 1-4 + matched. * *

Carbaryl (1: 5) 20 + 100 100 80

Example B

Phaedon cochleariae - larval test

Solvent: 78 parts by weight of acetone

1.5 parts by weight of dimethylformamide

Emulsifier: 0.5 part by weight of alkylaryl polyglycol ether

To prepare a suitable preparation of active compound, 1 part by weight of active compound is mixed with the indicated amounts of solvent and emulsifier, and the concentrate is diluted with emulsifier-containing water to the desired concentration.

Cabbage leaves (Brassica oleraceä) are by spraying with the active ingredient preparation in the desired Concentrated and treated with larvae of the horseradish leaf beetle {Phaedon cochleariae), as long as the leaves are still moist.

After the desired time the kill is determined in%. 100% means that all beetle larvae have been killed; 0% means that no beetle larvae have been killed. The determined kill values are calculated according to the Colby formula.

In this test, the following active ingredient combinations showed a synergistically enhanced efficacy compared to the individually applied active ingredients:

Table B - 1: Phaedon cochleariae larval test

Drug concentration killing

in g / ha in% after 2 ^d

Compound of formula 1-4

20 50

4 0

0.8 0

1- [2-fluoro-4-methyl-5 - [(2,2,2-trifluoroethyl) sulfinyl] phenyl] -3- 100

(trifluoromethyl) -1H-1, 2,4-triazole-5-amine

Compound of the formula 1-4 + 1- [2- gef. * over. * *

Fluoro-4-methyl-5 - [(2,2,2- 20 + 100 100 50

Mixture of 1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl-6 - 0.8 67

[(Methylamino) carbonyl] phenyl] -3

[[5- (trifluoromethyl) -2H-tetrazol-2-yl] methyl] -1H-pyrazole-5-carboxamide and 1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl-6 [(methylamino) carbonyl] phenyl] - 3 - [[5- (trifluoromethyl) -1H-tetrazol-1-ylmethyl] -1H-pyrazole-5-carboxamide (ca 91: 9)

Compound of formula 1-4 + matched. * *

Mixture of 1- (3-chloro-2-4 + 0.8 100 67

pyridinyl) -N- [4-cyano-2-methyl-6 - [(methylamino) carbonyl] phenyl] -3

[[5- (trifluoromethyl) -2H-tetrazol-2-yl] methyl] -1H-pyrazole-5-carboxamide and 1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl] 6 [(methylamino) carbonyl] phenyl] - 3 - [[5- (trifluoromethyl) -1H-tetrazol-1-ylmethyl] -1H-pyrazole-5-carboxamide (5: 1)

4 - {[(6-01 / 1) -3-) ηΐ6 1] (2,2-difluoroethyl) amino} furan-2 (5H) -one 500-50

Compound of the formulas 1-4 + 4 - {[(6-dibenz * * chloropyrid-3-yl) methyl] (2,2- 20 + 500 100 75 difluoroethyl) amino} furan-2 (5H) - on

(1:25)

fipronil

0.8 33

Compound of formula 1-4 + found. * * Fipronil (1: 1) 0.8 + 0.8 100 33

* gef. = found effect

** calc. = calculated according to the Colby formula

Table B - 2: Phaedon cochleariae larval test

Active substance concentration killing in g / ha in% after 6 ^d

Compound of formula 1-4

20 33

4 0

0.8 0

flonicamid

4 0

Compound of formula 1-4 + gef. * calc. * * Flonicamid (1: 1) 4 + 4 33 0

clothianidin

4 0

Compound of formula 1-4 + found. * * Clothianidin (5: 1) 20 + 4 67 33

dinotefuran

4 0

Compound of formula 1-4 + found. * * Dinotefuran (1: 1) 4 + 4 67 0

abamectin

0.16 33

Compound of formula 1-4 + found. * * Abamectin (125: 1) 20 + 0.16 100 55.11

Emamectin benzoate

0.16 67 Active substance concentration killing in g / ha in% after 6 ^d

Compound of formula 1-4 + found. * * Emamectin benzoate (125: 1) 20 + 0.16 100 77.89

acephate

100 0

Compound of formula 1-4 + found. * * Acephate (1: 5) 20 + 100 67 33

methiocarb

20 0

Compound of formula 1-4 + found. * * Methiocarb (1: 1) 20 + 20 67 33

Beta-cyfluthrin

0.16 0

Compound of Formula 1-4 + Beta-F. * * Cyfluthrin (25: 1) 4 + 0.16 33 0

deltamethrin

0.16 0

Compound of formula 1-4 + found. * * Deltamethrin (25: 1) 4 + 0.16 50 0

spinosad

4 33

Compound of Formula 1-4 + found. * * Spinosad (5: 1) 20 + 4 100 55.11

ethiprole

0.16 0

Compound of formula 1-4 + found. * * Ethiprole (5: 1) 0.8 + 0.16 33 0

indoxacarb

4 33

Compound of formula 1-4 + found. * * Indoxacarb (1: 1) 4 + 4 67 33

chlorfenapyr

4 0

Compound of formula 1-4 + found. * * Chlorfenapyr (1: 1) 4 + 4 33 0 gef. = found effect

* calc. = calculated according to the Colby formula Example C

Spodoptera frugiperda - larval test

Solvent: 78 parts by weight of acetone

1.5 parts by weight of dimethylformamide

Emulsifier: 0.5 part by weight of alkylaryl polyglycol ether

Cabbage leaves {Brassica oleracea) are treated by spraying with the preparation of active compound in the desired concentration and are infested with the armyworm {Spodoptera frugiperda) while the leaves are still moist.

After the desired time the kill is determined in%. 100% means that all caterpillars have been killed; 0% means that no caterpillars have been killed. The determined kill values are calculated according to the Colby formula.

Table C - 1: Spodoptera frugiperda larvae test

Drug concentration killing

in g / ha in% after 2 ^d

Compound of formula 1-4

100 0

20 0

4 0

0.8 0

Mixture of 1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl-6 - 0.16 67

[(Methylamino) carbonyl] phenyl] -3

[[5- (trifluoromethyl) -2H-tetrazol-2-yl] methyl] -1H-pyrazole-5-carboxamide and 1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl-6 [(methylamino) carbonyl] phenyl] - 3 - [[5- (trifluoromethyl) -1H-tetrazol-1-ylmethyl] -1H-pyrazole-5-carboxamide (ca 91: 9) Active substance concentration killing in g / ha in% after 2 ^d

Compound of formula 1-4 + gef. * * * Mixture of 1- (3-chloro-2-0,8 + 0,16,11,15,65-pyridinyl) -N- [4-cyano-2-methyl-6 - [(methylamino) carbonyl] phenyl] - 3

[[5- (trifluoromethyl) -2H-tetrazol-2-yl] methyl] -1H-pyrazole-5-carboxamide and 1- (3-chloro-2-pyridinyl) -N- [4-cyano-2-methyl] 6 [(methylamino) carbonyl] phenyl] - 3 - [[5- (trifluoromethyl) -1H-tetrazol-1-yl] methyl] -1H-pyrazole-5-carboxamide (5: 1)

flubendiamide

4 33

Compound of formula 1-4 + gef. * over. * * Flubendiamide (5: 1) 20 + 4 67 33

indoxacarb

4 50

Compound of formula 1-4 + gef. * over. * * Indoxacarb (1: 1) 4 + 4 100 50

novaluron

100 50

Compound of formula 1-4 + gef. * about. * * Novaluron (1: 1) 100 + 100 83 50

methamidophos

100 0

Compound of formula 1-4 + gef. *. * * Methamidophos (1: 5) 20 + 100 33 0

acrinathrin

4 67

Compound of formula 1-4 + gef. * acrinathrin (5: 1) 20 + 4 100 67

transfluthrin

20 33

Compound of formula 1-4 + gef. * trans. * * transfluthrin (1: 5) 4 + 20 67 33 gef. = found effect

* calc. = calculated according to the Colby formula Table C-2:

Active substance concentration killing in g / ha in% after 6 ^d

Compound of formula 1-4 + found. * * Diafenthiuron (1: 1) 100 + 100 100 33

profenofos

20 0

Compound of formula 1-4 + found. * * Profenofos (1: 1) 20 + 20 83 0

triflumuron

20 50

Compound of formula 1-4 + found. * * Triflumuron (1: 1) 20 + 20 100 50

methoxyfenozide

20 0

Compound of formula 1-4 + found. * * Methoxyfenozide (1: 1) 20 + 20 33 0

tebufenozide

20 0

Compound of Formula 1-4 + found. * * Tebufenozide (1: 1) 20 + 20 67 0

cypermethrin

0.8 0

Compound of formula 1-4 + found. * * Cypermethrin (1: 1) 0.8 + 0.8 67 0 gef. = found effect

* calc. = calculated according to the Colby formula

Example D

Tetranychus test (surgical-resistant / spray treatment)

Solvent: 78 parts by weight of acetone

1.5 parts by weight of dimethylformamide emulsifier: 0.5 part by weight of alkylaryl polyglycol ether

Bean leaf discs (Phaseolus vulgaris), which are infected by all stages of the common spider mite (Tetranychus urticae), are sprayed with an active compound preparation in the desired concentration.

After the desired time, the effect is determined in%. 100% means that all spider mites have been killed; 0% means that no spider mites have been killed.

In this test, the following drug combinations showed a synergistically enhanced efficacy compared to the individual drugs: Table D - 1: Tetranychus urticae test

Drug concentration killing

in g / ha in% after 2 ^d

Compound of formula 1-4

100 0

20 0

spiromesifen

4 0

Compound of formula 1-4 + gef. * over. * *

Spiromesifen (5: 1) 20 + 4 70 0

spirodiclofen

100 20

Compound of formula 1-4 + matched. * *

Spirodiclofen (1: 1) 100 + 100 90 20

deltamethrin

4 0

Compound of formula 1-4 + matched. * *

Deltamethrin (25: 1) 100 + 4 40 0 Active substance concentration killing in g / ha in% after 2 ^d

spinetoram

4 0

Compound of formula 1-4 + matched. **

Spinetoram (25: 1) 100 + 4 90 0

aldicarb

4 0

Compound of formula 1-4 + matched. **

Aldicarb (1: 1) 20 + 20 70 0

* gef. = found effect

** calc. = calculated according to the Colby formula

Table D - 2:

Active substance concentration killing in g / ha in% after 6 ^d

Compound of formula 1-4

100 0

20 0

4 0

0.8 0

chlorpyrifos

20 0

Compound of formula 1-4 + matched. **

Chlorpyrifos (1: 1) 20 + 20 70 0

acephate

500 0

Compound of formula 1-4 + matched. **

Acephate (1: 5) 100 + 500 30 0

thiodicarb

100 0

Compound of formula 1-4 + matched. **

Thiodicarb (1: 1) 100 + 100 20 0

Lambda-cyhalothrin

0.032 0

Compound of formula 1-4 + matched. **

Lambda-Cyhalothrin (25: 1) 0.8 + 0.032 30 0

Beta-cyfluthrin

0.8 0

Compound of Formula 1-4 + Beta Fever. **

Cyfluthrin (25: 1) 20 + 0.8 70 0 Active substance concentration killing in g / ha in% after 6 ^d

spinosad

4 40

Compound of formula 1-4 + gef. * over. * * Spinosad (5: 1) 20 + 4 80 40

carbofuran

100 0

Compound of formula 1-4 + gef. * calc. * * Carbofuran (1: 1) 100 + 100 20 0

flufenoxuron

20 10

Compound of formula 1-4 + gef. *. * * Flufenoxuron (5: 1) 100 + 20 90 10

fenpyroximate

0.8 30

Compound of formula 1-4 + gef. * over. * * Fenpyroximate (5: 1) 4 + 0.8 90 30

tebufenpyrad

4 70

Compound of formula 1-4 + gef. * over. * * Tebufenpyrad (1: 1) 4 + 4 90 70

Gamma-cyhalothrin

0.16 20

Compound of formula 1-4 + gef. * calc. * * gamma-cyhalothrin (25: 1) 4 + 0,16 70 20

methamidophos

500 30

Compound of formula 1-4 + gef. *. * * Methamidophos (1: 5) 100 + 500 70 30

bifenthrin

0.8 80

Compound of formula 1-4 + gef. * over. * * Bifenthrin (25: 1) 20 + 0.8 100 80

carbaryl

100 0

Compound of formula 1-4 + gef. * calc. * * Carbaryl (1: 5) 20 + 100 30 0

spirotetramate

4 70

Compound of formula 1-4 + gef. * over. * * Drug concentration killing

in g / ha in% after 6 ^d

Spirotetramat (25: 1) 100 + 4 100 70

1- [2-fluoro-4-methyl-5 - [(2,2,2-trifluoroethyl) sulfinyl] phenyl] -3- 0.8

(trifluoromethyl) -1H-1, 2,4-triazole-5-amine

Compound of the formula 1-4 + 1- [2- gef. * over. * *

Fluoro-4-methyl-5 - [(2,2,2- 0,8 + 0,8 90 0

trifluoroethyl) sulfinyl] phenyl] -3- (trifluoromethyl) -1H-1,2,4-triazole-5-amine (1: 1)

gef. = found effect

Calculated = calculated according to the Colby formula

Example E

Seed Treatment - Casserole test soybean

Seed of the soybean (Glycine max) is mixed with the desired amount of active ingredient and spores and water. After drying, 25 seeds each are sown in a pot of sandy loam soil.

After 4 days, the effect is determined in%. The effect is calculated on the basis of the number of accumulated soybean plants compared to the untreated control. The following active - spore combination showed a better start - up rate than the individually applied components and the control:

Table E: Casserole soybean

Active substance / spore concentration casserole in% compared

g ai / kg seed for untreated control

Control (untreated seed) 100

Compound of the formula 1-4 0.3 101.79

0.15 103.57

Bacillus firmus I - 1582 0.08 80.36

Compound of formula 1-4 + B. firmus I-0.3 + 0.08 107.14

1582 0.15 + 0.08 119.64

Claims

claims

1. Active substance combination comprising a compound of the formula (I)

in which

R ¹ represents in each case halo-substituted C ₂ -C ₄ alkyl, C ₂ -C ₅ alkenyl or C _3- C ₅ cycloalkyl,

R ^{2 is} in each case optionally halogen-substituted alkyl or cycloalkyl,

B represents optionally substituted methylene or in each case optionally substituted alkylene or alkylidene having in each case 2 to 6 carbon atoms, or denotes a bond between A and NR ¹ and one or more compounds selected from the compounds mentioned below:

(1) Acetylcholinesterase (AChE) inhibitors, such as

Carbamates, e.g. Alanycarb, Aldicarb, Bendiocarb, Benfuracarb, Butocarboxime, Butoxycarboxime, Carbaryl, Carbofuran, Carbosulfan, Ethiofencarb, Fenobucarb, Formetanate, Furathiocarb, Isoprocarb, Methiocarb, Methomyl, Metolcarb, Oxamyl, Pirimicarb, Propoxur, Thiodicarb, Thiofanox, Triazamate, Trimethacarb, XMC and xylylcarb;

Organophosphates, eg, acephates, azamethiphos, azinphos-ethyl, azinphos-methyl, cadusafos, chloroethoxyfos, chlorfenvinphos, chlormephos, chlorpyrifos, chlorpyrifos-methyl, coumaphos, cyanophos, demeton-S-methyl, diazinon, dichlorvos / DDVP, dicrotophos, dimethoates, dimethylvinphos , Disulfonot, EPN, Ethion, Ethoprophos, Famphur, Fenamiphos, Fenitrothion, Fenthion, Fosthiazate, Heptenophos, Imicyafos, Isofenphos, Isopropyl O- (methoxyaminothio-phosphoryl) salicylate, isoxathione, malathion, mecarbam, methamidophos, methidathione, mevinphos, monocrotophos, naled, omethoate, oxydemeton-methyl, parathion, parathion-methyl, phenthoates, phorates, phosalones, phosmet, phosphamidone, phoxim, pirimiphos-methyl, profenofos, propetamphos, Prothiofos, pyraclofos, pyridaphenthion, quinalphos, sulfotep, tebupirimfos, temephos, terbufos, tetrachlorvinphos, thiometone, triazophos, triclorfone and vamidothion,

(2) GABA-controlled chloride channel antagonists, such as cyclodiene organochlorines, e.g. Chlordane and endosulfan; Phenylpyrazoles (fiproles), e.g. Ethiprole and fipronil,

Pyrethroids, e.g. Acrinathrin, allethrin, d-cis-trans allethrin, d-trans allethrin, bifenthrin, bioallethrin, bioallethrin S-cyclopentenyl isomer, bioresmethrin, cycloprothrin, cyfluthrin, beta-cyfluthrin, cyhalothrin, lambda-cyhalothrin, gamma-cyhalothrin, cypermethrin, alpha Cypermethrin, beta-cypermethrin, theta-cypermethrin, zeta-cypermethrin, cyphenothrin [(lR) trans isomers], deltamethrin, empenthrin [(EZ) (lR) isomers], esfenvalerates, etofenprox, fenpropathrin, fenvalerates, flucythrinates, Flumethrin, tau-fluvalinate, halfenprox, imiprothrin, kadethrin, permethrin, phenothrin [(lR) -trans-isomer), prallethrin, pyrethrin (pyrethrum), resmethrin, silafluofen, tefluthrin, tetramethrin, tetramethrin [(1R) - isomer)], Tralomethrin and transfluthrin;

DDT; methoxychlor,

(4) nicotinergic acetylcholine receptor (nAChR) agonists, such as

Neonicotinoids, e.g. Acetamiprid, clothianidin, dinotefuran, imidacloprid, nitenpyram, thiacloprid and thiamethoxam;

Nicotine,

(5) nicotinergic acetylcholine receptor (nAChR) allosteric activators such as spinosines, e.g. Spinetoram and Spinosad,

(6) chloride channel activators, such as

Avermectins / milbemycins, eg abamectin, emamectin benzoate, lepimectin and milbemectin, (7) juvenile hormone imitators such as juvenile hormone analogs, eg, hydroprene, kinoprene and methoprene; fenoxycarb; pyriproxyfen,

(8) alkyl halides, e.g. Methyl bromide and other alkyl halides; chloropicrin; sulfuryl fluoride; Borax; Tartar emetic,

(9) Selective feeding inhibitors, e.g. pymetrozine; flonicamid,

(10) mite growth inhibitors, e.g. Clofentezine, hexythiazox and diflovidazine; etoxazole,

(11) Insect intestinal membrane microbial disruptors, e.g. Bacillus thuringiensis subspecies israelensis, Bacillus sphaericus, Bacillus thuringiensis subspecies aizawai, Bacillus thuringiensis

Subspecies kurstaki, Bacillus thuringiensis subspecies tenebrionis and BT plant proteins: CrylAb, CrylAc, CrylFa, Cry2Ab, mCry3A, Cry3Ab, Cry3Bb, Cry34 / 35Abl,

(12) inhibitors of oxidative phosphorylation, ATP disrupters such as diafenthiuron; Organotin compounds, e.g. Azocyclotine, cyhexatin and fenbutatin oxide; propargite; tetradifon,

(13) decoupling of oxidative phosphorylation by interruption of the H proton gradient, such as chlorfenapyr, DNOC and sulfluramide,

(14) nicotinergic acetylcholine receptor antagonists such as bensultap, cartap hydrochloride, thiocyclam and thiosultap sodium, (15) type 0 inhibitors of chitin biosynthesis, such as bistrifluron, chlorofluoroburon,

Diflubenzuron, flucycloxuron, flufenoxuron, hexaflumuron, lufenuron, novaluron, noviflumuron, teflubenzuron and triflumuron,

(16) inhibitors of chitin biosynthesis, type 1, such as buprofezin,

(17) Moisturizing agents, dipteran, such as cyromazine, (18) ecdysone receptor agonists, such as chromafenozides, halofenozides, methoxyfenozides and tebufenozides,

(19) octopaminergic agonists, such as amitraz,

(20) complex III electron transport inhibitors such as hydramethylnone; or acequinocyl; or fluacrypyrim,

(21) Complex I electron transport inhibitors, for example

METI acaricides, e.g. Fenazaquin, Fenpyroximate, Pyrimidifen, Pyridaben, Tebufenpyrad and Tolfenpyrad;

Rotenone (Derris),

(22) voltage dependent sodium channel blockers, e.g. indoxacarb; or metaflumizone,

(23) inhibitors of acetyl-CoA carboxylase, such as

Tetronic and tetramic acid derivatives, e.g. Spirodiclofen, spiromesifen and spirotetramat,

(24) complex IV electron transport inhibitors such as

Phosphines, e.g. Aluminum phosphide, calcium phosphide, phosphine and zinc phosphide; cyanide,

(25) complex II electron transport inhibitors, such as cyenopyrafen,

(28) ryanodine receptor effectors such as diamides, e.g. Chlorantraniliproles and flubendiamides,

(29) other active ingredients such as amidoflumet, azadirachtin, benclothiaz, benzoximate, bifenazate, bromopropylate, quinomethionate, cryolites, cyanotraniliprole (cyazypyr), cyflumetofen, dicofol, diflovidazine, fluensulfone, flufenerim, flufiprole, fluopyram, fufenocide, imidaclothiz, iprodione, meperfluthrin , Pyralidyl, pyrifluquinazone, tetramethylfluthrin and iodomethane; furthermore preparations based on Bacillus firmus (in particular strain CNCM 1-1582, for example VOTiVO ™, BioNem) and also 3-bromo-N- {2-bromo-4-chloro-6 - [(1-cyclopropylethyl) carbamoyl] phenyl} 1- (3-chloropyridin-2-yl) -1H-pyrazole-5-carboxamide (known from WO2005 / 077934), 4- {[(6-bromopyrid-3-) yl) methyl] (2-fluoroethyl) amino} furan-2 (5H) -one (known from WO2007 / 115644), 4 - {[(6-halo) τ (1-3-yl) methyl] (2,2 -difluoroethyl) amino} furan-2 (5H) -one (known from WO2007 / 115644), 4 - {[(2-chloro-1,3-thiazol-5-yl) methyl] (2-fluoroethyl) amino} furan -2 (5H) -one (known from WO2007 / 115644), 4 - {[(6-chloropyrid-3-yl) methyl] (2-fluoroethyl) amino} furan-2 (5H) -one (known from WO2007 / 1 1 5644), flupyradifurones, 4 - {[(6-chloro-5-fluoropyrid-3-yl) methyl] (methyl) amino} furan-2 (5H) -one (known from

WO2007 / 115643), 4 - {[(5,6-Dichloropyrid-3-yl) methyl] (2-fluoroethyl) amino} furan-2 (5H) -one (known from WO2007 / 115646), 4 - {[( 6-chloro-5-fluoropyrid-3-yl) methyl] (cyclopropyl) amino} furan-2 (5H) -one (known from WO2007 / 115643), 4 - {[(6-chloro-3-yl) methyl] ] (cyclopropyl) amino} furan-2 (5H) -one (known from EP-A-0 539 588), 4 - {[(6-chloro-3-yl) methyl] -methyl) amino} furan -2 (5H) -one (known from EP-A-0 539 588), {[1- (6-chloropyridin-3-yl) ethyl] (methyl) oxido-λ ⁴ -sulfanylidene} cyanamide (known from

WO2007 / 149134) and its diastereomers {[(1R) -1- (6-chloropyridin-3-yl) ethyl] (methyl) oxido- ⁴ -sulfanyliden} cyanamide (A) and {[(1S) -1] 6-chloro-pyridin-3-yl) -ethyl] (methyl) -oxo- ⁴ -sulfanylidene-cyanamide (B) (also known from WO2007 / 149134) and sulfoxaflor and its diastereomers [(R) -methyl (oxido) {(IR) l- [6- (trifluormemyl) pyridin-3-yl] ethyl} - ⁴ - sulfanyliden] cyanamide (AI) and [(S) -Memyl (oxido) {(lS) -l- [6- (trifluoromethyl) pyridine 3-yl] ethyl} - ⁴ -sulfanylidene] cyanamide (A2), referred to as diastereomeric group A (known from WO 2010/074747, WO 2010/074751), [(R) -male (oxido) {(IS) - l- [6- (trifluoromethyl) pyridin-3-yl] ethyl} - ⁴ - sulfanyliden] cyanamide (Bl) and [(S) -Memyl (oxido) {(lR) -l- [6- (trifluormemyl) pyridine 3-yl] ethyl} - ⁴ -sulfanylidene] cyanamide (B2), referred to as diastereomeric group B (also known from WO 2010/074747, WO 2010/074751) and 1- (4-chloro-2,6-dimethylphenyl) - 12-hydroxy-1,4-dioxa-9-azadispiro [4.2.4.2] tetradec-1-en-10-one (available on W 02 00 6/0 8 9 63 3) , 3- (4'-fluoro-2,4-dimethylbiphenyl-3-yl) -4-hydroxy-8-oxa-1-azaspiro [4.5] dec-3-en-2-one (known from WO2008 / 067911) , 1 - {2-Fluoro-4-methyl-5 - [(2,2,2-trifluoroethyl) sulfinyl] phenyl} -3- (trifluoromethyl) -1 H -1, 2,4-triazole-5-amine ( known from WO2006 / 043635), [(3S, 4aR, 12R, 12aS, 12bS) -3 - [(cyclopropylcarbonyl) oxy] -6,12-dihydroxy-4,12b-dimethyl-1-oxo-9- (pyridine 3-yl) -l, 3,4,4a, 5,6,6a, 12,12a, 12b-decahydro-2H, l 1H-benzo [f] pyrano [4,3-b] chromen-4-yl ] methylcyclopropanecarboxylate (known from WO2008 / 066153), 2-cyano-3- (difluoromethoxy) -N, N-dimethylbenzenesulphonamide (known from WO2006 / 056433), 2-cyano-3- (difluoromethoxy) -N-methylbenzenesulphonamide (known from WO2006 / 100288), 2-cyano-3- (difluoromethoxy) -N-ethylbenzenesulfonamide (known from WO2005 / 035486), 4- (difluoromethoxy) -N-ethyl-N-methyl-1,2-benzothiazol-3-amine-1, l-dioxide (known from WO2007 / 057407), N- [l- (2,3-)

Dimemylphenyl) -2- (3,5-dimemylphenyl) -emyl] -4,5-dihydro-l, 3-thiazol-2-amine (known from WO2008 / 104503), {l '- [(2E) -3- ( 4-chloro-1-yl) prop-2-en-1-yl] -5-fluorospiro [indole-3,4'-piperidin] -1 (2H) -yl} (2-chloropyridin-4-yl) -methanone (known from WO2003 / 106457), 3- (2,5-dimethylphenyl) -4-hydroxy-8-methoxy-1,8-diazaspiro [4.5] dec-3-en-2-one (known from WO2009 / 049851), 3 - (2,5-dimethylphenyl) - 8-methoxy-2-oxo-l, 8-diazaspiro [4.5] dec-3-en-4-yl-ethyl carbonate (known from WO2009 / 049851), 4- (but-2-yn-1-yloxy) -6 - (3,5-dimethylpiperidin-1-yl) -5-fluoropyrimidine (known from WO2004 / 099160), (2,2,3,3,4,4,5,5-octafluoropentyl) (3,3,3- trifluoropropyl) malononitrile (known from WO2005 / 063094), (2,2,3,3,4,4,5,5-octafluoropentyl) (3,3,4,4,4-pentafluorobutyl) malononitrile (known from WO2005 / 063094 ), 8- [2- (cyclopropylmethoxy) -4- (trifluoromethyl) phenoxy] -3- [6- (trifluoromethyl) pyridaz

azabicyclo [3.2.1] octane (known from WO2007 / 040280), flometoquine, PF 1364 (CAS No. 1204776- 60-2) (known from JP2010 / 018586), 5- [5- (3,5-) Dichloro) -5- (trifluoromethyl) -4,5-dihydro-l, 2-oxazol-3-yl] -2- (1H-l, 2,4-triazol-1-yl) benzonitrile (known from WO2007 No. / 075,459), 5- [5- (2-chloro-4-yl) -5- (trifluoromethyl) -4,5-dihydro-1,2-oxazol-3-yl] -2- (1H-1 , 2,4-triazol-1-yl) benzonitrile (known from WO2007 / 075459), 4- [5- (3,5-dichloro) -5- (trifluoromel) -4,5-dihydro-1, 2-oxazol-3-yl] -2-methyl-N- {2-oxo-2 - [(2,2,2-trifluoroethyl) amino] ethyl} benzamide (known from WO2005 / 085216), 4 - {[( 6-chloro-pyridin-3-yl) -methyl] (cyclopropyl) -amino} -l, 3-oxazol-2 (5H) -one,

yl) methyl] (2,2-difluoroethyl) amino} -1,3-oxazol-2 (5H) -one, 4 - {[(6-chk-yridin-3-yl) methyl] (ethyl) amino} - l, 3-oxazol-2 (5H) -one, 4 - {[(6-chloro-pyridin-3-yl) -methyl] (methyl) -amino} -l, 3-oxazol-2 (5H) -one (all known from WO2010 / 005692), N I-0711 (known from WO2002 / 096882), 1-acetyl-N- [4- (1,1,3,3,3,3-hexafluoro-2-methoxypropan-2-yl) 3 -isobutylphenyl] -N-isobutyl-3,5-dimethyl-1H-pyrazole-4-carboxamide (known from WO2002 / 096882), methyl 2- [2 - ({[3-bromo-1- (3- chloro-2-yl) -1H-pyrazol-5-yl] carbonyl} amino) -5-chloro-3-methylbenzoyl] -2-methylhydrazinecarboxylate (known from WO2005 / 085216), Me l-2- [2- (2- {[3-Bromo-1- (3-chloro-2-yl) -1H-pyrazol-5-yl] carbonyl} -amino) -5-cyano-3-methylbenzoyl] -2-ethylhydrazinecarboxylate (known from WO2005 / No. 085216), methyl 2- [2 - ({[3-bromo-1- (3-chloro-2-pyridin-1-yl) -l-pyrazol-5-yl] -carbonyl} -amino) -5-cyano-3-methylbenzoyl] 2-methylhydrazinecarboxylate (known from WO2005 / 085216), methyl 2- [3,5-dibromo-2 - ({[3-bromo-1- (3-chloro-2-yl) -1H-pyrazole-5 yl] carbonyl} amino) ben zoyl] -1,2-diethylhydrazinecarboxylate (known from WO2005 / 085216), methyl 2- [3,5-dibromo-2 - ({[3-bromo-1- (3-chloro-2-yl) -l-1] H-pyrazole-5-yl] carbonyl} amino) benzoyl] -2-ethylhydrazinecarboxylate (known from WO2005 / 085216), (5RS, 7RS; 5RS, 7SR) -1- (6-chloro-3-pyridylmethyl) -1-methylene , 2,3,5,6,7-hexahydro-7-methyl-8-nitro-5-propoxyimidazo [1,2-a] pyridine (known from WO2007 / 101369), 1- (3-chloropyridin-2-yl ) -N- [4-cyan-2-methyl-6 - (methylcarbamoyl) phenyl] -3 - {[5 - (trifluoromethyl) -1 H -tetrazol-1-ylmethyl} -1 H -pyrazole-5-carboxamide (known from WO2010 / 069502), 1- (3-chloropyridin-2-yl) -N- [4-cyano-2-methyl-6- (methylcarbamoyl) phenyl] -3 - {[5- (trifluoromethyl) -2H tetrazol-2-yl] methyl} -1H-pyrazole-5-carboxamide (known from WO2010 / 069502), N- [2- (tert-butylcarbamoyl) -4-cyano-6-methylphenyl] -1- (3 chloφyridin-2-yl) -3 - {[5 - (trifluoromethyl) -1 H -tetrazol-1-yl] methyl} -1 H -pyrazole-5-arb ox on id (available from WO2010 / 069502) , N- [2- (tert -butylcarbamoyl) -4-cyano-6-methylphenyl] -1- (3-chloro-2-yr) l) -3 - {[5- (trifluoromethyl) -2H-tetrazol-2-yl] methyl} -1H-pyrazole-5-carboxamide (known from WO2010 / 069502), N- [2- (5-Amino-1,3,3,4-thiadiazol-2-yl) -4-chloro-6-methylphenyl] -3-bromo-1- (3-chloropyridin-2-yl) -1 H -pyrazole 5-carboxamide (known from CN102057925) and methyl 2- [3,5-dibromo-2 - ({[3-bromo-1- (3-chloropyridin-2-yl) -1H-pyrazole-5-ylcarbonyl] } amino) benzoyl] -2-ethyl-1-methylhydrazinecarboxylate (known from WO2011 / 049233), (F1) inhibitors of nucleic acid synthesis, for example benalaxyl, benalaxyl-M, bupirimat,

Clozylacon, dimethirimol, ethirimol, furalaxyl, hymexazole, metalaxyl, metalaxyl-M, ofurace, oxadixyl and oxolinic acid,

(F-2) inhibitors of mitosis and cell division, such as benomyl, carbendazim, chlorfenazole, diethofencarb, ethaboxam, fuberidazole, pencycuron, thiabendazole, thiophanate, thiophanate-methyl and zoxamide,

(F-3) inhibitors of respiration (respiratory chain inhibitors), such as diflumetorim as an inhibitor at complex I of the respiratory chain; Bixafen, boscalid, carboxin, fenfuram, flutolanil, fluopyram, furametpyr, Furmecyclox, Isopyrazam (mixture of the sy "epimers racemate \ RS, 4SR, 9RS and the AWFT ^'epimers racemate \ RS, 4SR, 9SR) Isopyrazam (sy "-Pimeric racemate \ RS, 4SR, 9RS), isopyrazam (sy" -epimeric enantiomer \ R, 4S, 9R), isopyrazam (sy "-epimeres

Enantiomer \ S, 4R, 9S), isopyrazam (awft ^' epimeric racemate \ RS, 4SR, 9SR), isopyrazam (awft ^' epimeric enantiomer 1R, 4S, 9S), isopyrazam (awft ^' epimeric enantiomer \ S, 4R, 9R)

Mepronil, oxycarboxin, penflufen, penthiopyrad, sedaxane, thifluzamide as inhibitors of complex II of the respiratory chain; Amisulbrom, azoxystrobin, cyazofamide, dimoxystrobin, enestroburin,

Famoxadone, fenamidone, fluoxastrobin, kresoxim-methyl, metominostrobin, orysastrobin,

Picoxystrobin, pyraclostrobin, pyraoxystrobin, pyrametostrobin, pyribencarb, trifloxystrobin,

(F-4) decouplers such as binapacryl, dinocap, fluazinam and meptyldinocap,

(F-5) inhibitors of ATP production, such as fentin acetate, fentin chloride, fentin hydroxide and silthiofam, (F-6) inhibitors of amino acid and protein biosynthesis, such as andoprim, blasticidin

S, cyprodinil, kasugamycin, kasugamycin hydrochloride hydrate, mepanipyrim and pyrimethanil,

(F-7) signal transduction inhibitors such as fenpiclonil, fludioxonil and quinoxyfen, (F-8) inhibitors of lipid and membrane synthesis, such as biphenyl, chlozolinate, edifenphos, etridiazole, iodocarb, Iprobenfos, iprodione, isoprothiolane, procymidone, propamocarb, propamocarb hydrochloride, pyrazophos, tolclofos-methyl and vinclozolin,

(F-9) inhibitors of ergosterol biosynthesis, such as aldimorph, azaconazole, bitertanol, bromuconazole, cyproconazole, diclobutrazole, difenoconazole, diniconazole, diniconazole-M,

Dodemorph, Dodemorph Acetate, Epoxiconazole, Etaconazole, Fenarimol, Fenbuconazole, Fenhexamid, Fenpropidin, Fenpropimorph, Fluquinconazole, Flurprimidol, Flusilazole, Flutriafol, Furconazole, Furconazole Cis, Hexaconazole, Imazalil, Imazalil Sulfate, Imibenconazole, Ipconazole, Metconazole, Myclobutanil, Naftifine, Nuarimol, oxpoconazole, paclobutrazole, pefurazoate, penconazole, piperaline, prochloraz, propiconazole, prothioconazole, pyributicarb, pyrifenox, quinconazole, simeconazole,

Spiroxamine, tebuconazole, terbinafine, tetraconazole, triadimefon, triadimenol, tridemorph, triflumizole, triforin, triticonazole, uniconazole, viniconazole and voriconazole,

(F-10) inhibitors of cell wall synthesis, such as benthiavalicarb, dimethomorph, flumorph, iprovalicarb, mandipropamide, polyoxins, polyoxorim, prothiocarb, validamycin A and valefenalate,

(F-l l) inhibitors of melanin biosynthesis, such as, for example, carpropamide, diclocymet, fenoxanil, fthalide, pyroquilone and tricyclazole,

(F-12) resistance inducers, such as acibenzolar-S-methyl, probenazole and tiadinil,

(F-13) Compounds with multisite activity, such as Bordeaux mixture, captafol, captan, chlorothalonil, copper naphthenate, copper oxide, copper oxychloride, copper preparations, such as

Copper hydroxide, copper sulfate, dichlorofluanide, dithianone, dodine and its free base, ferbam, fluorofolpet, folpet, guazatine, guazatine acetate, iminoctadine, iminoctadinalbe silate, iminoctadine triacetate, mancopper, mancozeb, maneb, metiram, zinc metiram, copper oxine, propamidine, propineb, sulfur and sulfur preparations such as calcium polysulfide, thiram, tolylfluanid, zineb and ziram,

(F-14) Other compounds such as 2,3-dibutyl-6-chlorothieno [2,3-d] pyrimidin-4 (3H) -one, (2Z) -3-amino-2-cyano-3-phenylprop -2-enoic acid ethyl ester, N- [2- (1, 3-dimethylbutyl) phenyl] -5-fluoro-1,3-dimethyl-1H-pyrazole-4-carboxamide, 3- (difluoromethyl) -1-methyl-N- (3 ', 4', 5 '- trifluorobiphenyl-2-yl) -1H-pyrazole-4-carboxamide, 3- (difluoromethyl) -N- [4-fluoro-2- (1,1,3,3,3 , 3-hexafluoropropoxy) phenyl] -l-methyl-1H-pyrazole-4-carboxamide, (2 lbs) -2- (2 - {[6- (3-chloro-2- methylphenoxy) -5-fluoropyrimidin-4-yl] oxy} phenyl) -2- (methoxyimino) -N-methylethaneam (2E) -2- {2 - [({[(2?, 3?) - 4- ( 2,6-dichloro) but-3-en-2-ylidene] amino} oxy) methyl] phenyl} -2- (methoxyimino) -N-methylethaneamide, 2-chloro-N- (1, 1, 3-trimethyl 1-2,3-dihydro-1H-inden-4-yl) pyridine-3-carboxamide, N- (3-ethyl-3,5,5-trimethylcyclohexyl) -3- (formylamino) -2-hydroxybenzamide, 5 - Methoxy-2-methyl-4- (2- {[({(II) -1- [3 - (trifluoromethyl) phenyl] ethylidene} amino) oxy] methyl} phenyl) -2,4-dihydro-3H- l, 2,4-triazol-3-one, (2 lb) -2- (methoxyimino) -N-methyl-2- (2- {[({(l) -l- [3- (trifluoromethyl) phenyl ] emylidene} amino) oxy] methyl} phenyl) ethanamide, (2E) -2- (methoxyimino) -N-methyl-2- {2 - [(i?) - ({1- [3- (trifluoromethyl) phenyl ] ethoxy} imino) meth (2E) -2- {2- [({[(IE) -l- (3 - {[(i) -l-fluoro-2-phenyl-enyl] oxy

(methoxyimino) -N-methylethaneamide, 1- (4-chlorohexyl) -2- (1H-1,2,4-triazol-1-yl) cycloheptanol, 1- (2,2-dimethyl-2,3-dihydro -lH-inden-l-yl) -lH-imidazole-5-carboxylic acid methyl ester, N-ethyl-N-methyl-N'- {2-methyl-5 - (trifluoromethyl) -4- [3 - (trimethylsilyl) propoxy] phenyl} imidoformamide, N '- {5- (difluoromethyl) -2-memyl-4- [3- (trimethylsilyl) propoxy] phenyl} -N-ethyl-N-methoxy- {1 - [(4-methoxyphenoxy) methyl] -2,2-dimethylpropyl} 1 Η -imidazole-1-carbothioate, N- [2- (4- {[3- (4-chlorohexyl) prop-2-yn-1-yl] oxy} -3 -methoxyphenyl) ethyl] -N ² - (memylsulfonyl) valinamine 5-Chloro-7- (4-methylpiperidin-1-yl) -6- (2,4,6-trifluoro-henyl) [1,2,4] triazolo [ l, 5-a] py rimidine, 5-amino-l, 3,4-thiadiazole-2-thiol, propamocarb-fosetyl, 1 - [(4-methoxyphenoxy) methyl] -2,2-dimethylpropyl-1H-imidazole 1-carboxylate, 1-methyl-N- [2- (1, 1, 2,2-tetrafluoroethoxy) phenyl] -3- (trifluoromethyl) -1H-pyrazole-4-carboxamide, 2,3,5,6-tetrachloro -4- (methylsulfonyl) pyridine, 2-butoxy-6-iodo-3-propyl-4H-chromen-4-one, 2-phenylphenol ol and its salts, 3- (difluoromethyl) -1-methyl-N- [2- (1,2,2-tetrafluoroethoxy) phenyl] -1H-pyrazole-4-carboxamide, 3,4,5-trichloropyridine 2,6-dicarbonitrile, 3- [5- (4-chlorophenyl) -2,3-dimethylisoxazolidin-3-yl] pyridine, 3-chloro-5- (4-chlorophenyl) -4- (2,6-difluorophenyl ) -6-methylpyridazine, 4- (4-chlorophenyl) -5- (2,6-difluorophenyl) -3,6-dimethylpyridazine, 8-hydroxyquinoline, 8-hydroxyquinoline sulfate, tebufloquine, 5-methyl-6-octyl-3, 7-dihydro [1,2,4] triazolo [1,5-a] pyrimidine-7-amine, 5-ethyl-6-octyl-3,7-dihydro [1,2,4] triazolo [1,5- a] pyrimidin-7-amine, ametoctradine, benthiazole, bethoxazine, capsimycin, carvone, quinomethionate, chloroneb, cufraneb, cyflufenamid, cymoxanil, cyprosulfamide, dazomet, debacarb, dichlorophen, diclomethine, dicloran, difenzoquat, difenzoquat methylsulphate, diphenylamine, ecomat, ferimzone , Flumetover, fluopicolide, fluoromide, flusulfamide, flutianil, fosetyl-aluminum, fosetyl-calcium, fosetyl-sodium, hexachlorobenzene, irumamycin, isotianil, methasulfocarb, ( 2 lb) -2- {2 - [({cyclopropyl [(4-methoxyphenyl) imino] methyl} thio) methyl] phenyl} -3-methoxyacrylic acid methyl ester, methyl isothiocyanate, metrafenone, (5-chloro-2-methoxy-4-methylpyridine 3-yl) (2,3,4-trimethoxy-6-methylphenyl) methanone, mildiomycin, tolnifanide, N- (4-chlorobenzyl) -3- [3-methoxy-4- (prop-2-yn-1 oxy) pheny1] propanamide, N - [(4-

-yloxy) phenyl] propanamide, N- [(5-bromo-3-chloro-2-yl) -methyl] -2,4-dichloro-pyridine-3-carboxamide, N- [1- (5-bromo-3-chk yridin-2-yl) ethenyl] -2,4-dichloro-3-yne-carboxamide, N- [1- (5-bromo-3-chloropyridin-2-yl) ethyl] -2-fluoro-4-iodopyridine 3-carboxamide, N - {(Z) - [(cyclopropylmethoxy) imino] [6- (difluoromethoxy) -2,3-difluoro-phenyl] methyl} -2-phenylacetamide, N - {(iT) - [(cyclopropylmethoxy) -imino] [6- (difluoromethoxy) -2,3-difluoro-phenyl] -metlylyl-2-phenylacetamide, natamycin, nickel dimethyldithiocarbamate, nitrothal-isopropyl, octilinone, oxamocarb, oxyfenthiine, β-β-1,3-α1-α1-α6-amino and its salts, phenazine-1-carboxylic acid, phenothrin, phosphoric acid and their salts, propamocarb Fosetylat, Propanosin- sodium, proquinazid, pyrrolnitrin, quintozene, 5 ^* prop-2-en-l-yl 5-amino-2- (l-methylethyl) -4- (2-methylphenyl) -3- oxo-2,3-dihydro-1H-pyrazole-1-carbothioate, tecloftalam, tecnazene, triazoxide, trichlamide, 5-chloro-N'-phenyl-N'-prop-2-yn-1-ylthiophene-2-sulfonohydrazide, Zarilamide, N-methyl 2- (1 - {- 5-methyl-3 - (trifluoromethyl) -1H-pyrazol-1-yl] -acetyl} -piperidin-4-yl) -N - [(\ R) -1,2,3,4- tetrahydronaphthalene-1-yl] -1,3-thiazole-4-c-arboxamide, N -methyl-2- (l - {[5-methyl-3 - (trifluoromethyl) -1H-pyrazol-1-yl] -acetyl} -piperidine -4-yl) -N- (1,2,3,4-tetrahydronaphthalen-1-yl) -1,3-thiazole-4-c arb oxamide, 3- (difluoromethyl) -N- [4-fluoro-2 - (1, 1,

2,3, 3,

3-hexafluoropropoxy) phenyl] -1-methyl-1H-pyrazole-4-carboxamide; and pentyl {6 - [({[(1-methyl-1H-tetrazol-5-yl) (phenyl) methylidene] amino} oxy ) methyl] pyridin-2-yl} carbamate.

Active substance combinations according to claim 1, wherein in the formula (I)

A is tetrahydrofuryl or pyrid-3-yl, which is optionally substituted in the 6-position by halogen, Ci-C4-alkyl or Ci-C4-haloalkyl or pyrimidin-5-yl, which is optionally substituted in the 2-position by halogen or C 1 -C ₄ -alkyl or by 1H-pyrazol-4-yl which is optionally substituted in the 1-position by C 1 -C ₄ -alkyl and in the 3-position by halogen or by 1H-pyrazol-5-yl which optionally substituted in the 3-position by halogen or C 1 -C ₄ -alkyl or isoxazol-5-yl which is optionally substituted in the 3-position by halogen or C 1 -C ₄ -alkyl or for 1, 2,4-oxadiazole -5-yl, which is optionally substituted in the 3-position by halogen or Ci-C alkyl or for 1-Methyl- l, 2,

4-triazol-3-yl, l, 2,5-thiadiazol-3-yl or for l, 3-thiazolyl-5-yl which is optionally substituted in the 2-position by halogen or Ci-C alkyl or for a rest

in which

X is halogen, Ci-C ₄ alkyl or Ci-C is ₄ haloalkyl and

Y represents halogen, _Ci-C4-alkyl, Ci-C stands or ₄ haloalkyl, Ci-C -haloalkoxy, azido or cyano

A is a residue from the series 5,6-difluoro-pyrid-3-yl, 5-chloro-6-fluoro-pyrid-3-yl, 5-bromo-6-fluoro-pyrid-3-yl, 5-iodo 6-fluoropyrid-3-yl, 5-fluoro-6-chloro-pyrid-3-yl, 5,6-dichloro-pyrid-3-yl, 5-bromo-6-chloro-pyrid-3-yl , 5-iodo-6-chloro-pyrid-3-yl, 5-fluoro-6-bromo-pyrid-3-yl, 5-chloro-6-bromo-pyrid-3-yl, 5,6-dibromo-pyrid 3-yl, 5-iodo-6-bromo-pyrid-3-yl, 5-fluoro-6-iodo-pyrid-3-yl, 5-chloro-6-iodo-pyrid-3-yl, 5-bromo 6-iodo-pyrid-3-yl, 5,6-diiodo-pyrid-3-yl, 5-methyl-6-fluoro-pyrid-3-yl, 5-methyl-6-chloro-pyrid-3-yl , 5-methyl-6-bromo-pyrid-3-yl, 5-methyl-6-iodo-pyrid-3-yl, 5-difluoromethyl-6-fluoropyrid-3-y 1, 5 -difluoromethyl-6 -chloro-pyrid-3-y 1, 5 -difluoromethyl-6-bromopyrid-3-yl and 5-difluoromethyl-6-iodo-pyrid-3-yl or

A for a rest

in which n is 2, 3 or 4 and Z is fluorine, chlorine or bromine, R ^{1 is} 2,2,2-trifluoroethyl or 2,2-difluoroethyl,

R ^{2 is} in each case optionally fluorine, chlorine or bromine-substituted methyl, ethyl, n-propyl, isopropyl, n-butyl, isobutyl, sec-butyl, tert-butyl, cyclopropyl or cyclobutyl,

B is -CR ³ R ⁴ - or -H ₂ C-CR ³ R ⁴ -, wherein

R ³ and R ⁴ are each independently hydrogen, each optionally substituted by halogen, substituted methyl, ethyl or C ₃ -C ₆ -cycloalkyl or halogen or dC ₄ -alkoxy-Ci-C ₄ alkyl, or

Active substance combinations according to Claim 1, where the compound of the formula (I)

is selected from the compounds of the formulas (1-1) to

(i-i i)

Active ingredient combinations according to claim 1, wherein the compound of formula (I) has the following

Owns structure.

5. Use of a combination of active substances according to one of claims 1 to 4 for controlling animal pests.

Use of a combination of active substances according to one of claims 1 to 4 for controlling unwanted microorganisms.

7. Use of a combination of active substances according to one of claims 1 to 4 for the treatment of seed.

8. Use of a combination of active substances according to one of claims 1 to 4 on transgenic plants. Process for the preparation of a plant protection agent, characterized in that an active substance combination according to one of Claims 1 to 4 is mixed with extenders and / or surface-active substances.